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THE CHARACTERIZATION OF Pb2+ TOXICITY IN RAT NEURAL DEVELOPMENT: AN 
ASSESSMENT OF Pb2+ EFFECTS ON THE GABA SHIFT IN NEURAL NETWORKS AND 
IMPLICATIONS FOR LEARNING AND MEMORY DISRUPTION 
By 
 
LORENZ SIMON NEUWIRTH 
 
Adviser: Professor Abdeslem El Idrissi, Ph.D. 
The toxic effects of Pb
2+
 on the developing rat nervous system has been investigated to  assess 
early developmental GABAergic disruption and its implications with altering inhibitory learning 
and memory. This goal was achieved using a multi-systems approach: blood lead levels (clinical 
physiology), qRT-PCR (molecular genetics), brain and primary neuronal culture immunology 
(immunohistochemical and cellular approaches), physiological cellular components 
(synaptosomes and protein expression) and finally through learning and memory assessment 
with GABA mimetic drug manipulations in the intact animal (behavioral pharmacology). The 
influence of a 956ppm Pb
2+
 gestational diet (i.e. from birth to sacrifice) resulted in pup mean 
blood lead levels (BLLs measured in μg/dL) (Range  28-47)  and Dams (Range 33-51) 
respectively. In contrast, control pups and dams were Pb
2+
 negative. These ages were selected to 
determine neurodevelopmental trajectories of the GABA-shift from excitation-to-inhibition 
postnatally in our model. qRT-PCR studies evinced a delay in mRNA expression regulating 
GAD 80, 65, CACAN β3, GABAAR and were differentially regulated cortex and hippocampus as 
a function of age in response to Pb
2+
.  Brain slice immunohistochemistry revealed an early shift 
of KCC2 expression in both cortex and hippocampus.  Notably, these alterations were 
differentially regulated by age, brain region and subcellular circuitry within structures (i.e. DG 
vs. CA3).  Neuronal cultures revealed that in response to Pb
2+




induced VSCC-β3 nuclear translocation and GABAAR upregulation. KCC2 expression was 
inhibiting in cultures by Pb
2+
.  Synaptosomal effects of Pb
2+ 
revealed altered glutamate 
accumulation and handling with increased spontaneous and decreased evoked release in 
significantly modulated by Pb exposure suggesting altered brain synaptogenesis. Pb
2+ 
 exposure 
resulted in increased binding suggesting post synaptic modification in cortex and hippocampus 
increasing brain excitability. Behaviorally, Pb
2+ 
exposure resulted in increased anxiety, 
impulsivity, stress, and disrupted learning and memory regulated by inhibitory circuits that were 
recovered with taurine, a GABAAR agonist, administration. Specifically, Pb
2+ 
disrupted 
contextual and auditory associative learning. Taken together, these results suggest that Pb
2+ 
interferes with early VSCCs and GABAAR synergistic action that establishes GABAergic neural 
networks and in turn produces increased brain excitability and over reactivity as a consequence 
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The Characterization of Pb
2+
 Toxicity in Rat Neural Development: 
An Assessment of Pb
2+
 effects on the GABA shift in neural networks and implications for 
learning and memory disruption. 
 
1.0 - Background and Significance: 
 




) is an antiquated poison with resourceful malleable metallic properties, yet its 
toxicity has been reported to result in various neurological disruptions, with particular sensitivity 
in the cortex, hippocampus, and cerebellum (Finkelstein et al., 1998). Goldstein (1992) first 
hypothesized that “Pb
2+
 may negatively affect early synaptogenesis disrupting early brain 
plasticity during critical stages of development.” Children are most vulnerable to Pb
2+
 
neurotoxicity due to an increase in absorbed lead via respiration and/or ingestion. In contrast, 
dermal absorption is rare and toxicity benign. Sixty percent of absorbed Pb
2+
 is cleared in urine 
via filtration in the kidneys (Chisolm et al., 1991). Absorbed Pb
2+
 enters the blood stream, 95% 
is transported by erythrocytes and distributed throughout the bodily organs; whereas 5% remains 
in the plasma (Lidsky and Schneider, 2003).  The half-life of Pb
2+
 in blood is ~ 35 days, ~ 2 
years in brain, and dependent upon the size and amount of calcium (Ca
2+
) accumulation in bone, 
it can remain circulating for decades (Lidsky and Schneider, 2003).  In addition, Pb
2+
 is 
transported into the brain by calcium-adenosine triphosphate enzyme pumps (Ca
2+
-ATPase) 
located on the endothelial cells that comprise the blood brain barrier (Kerper and Hinkle, 1997a). 
This route of brain lead deposition suggests an early susceptibility for children to be at increased 
risk for neurotoxicity during critical stages of brain development altering growth, myelination, 
synaptogenesis, and inhibitory regulation.  
Chelation therapy is an invaluable preventative measure for lowering Pb
2+
 toxicity. 
However, it fails to address the neurological sequelae associated with childhood Pb
2+
 poisoning 
(Toscano and Guilarte, 2001) due to continuous need for invasive procedures that children find 
aversive. Moreover, it does not prevent mobilization of skeletal Pb
2+
 stores that can persist years 
following exposure (e.g. the femur has a duration of Pb
2+
 mobilization from bone over a course 
of ~30 years post initial  exposure) (Gulson et al., 2003). Moreover, Pb
2+




bearing children can produce increased toxicity to their children by Pb
2+
 ability to enter the 
placenta (Hu and Hernandez-Avila, 2002).  Children chronically exposed to Pb
2+
 endure brain 
damage as evidenced by reductions of 0-5 intelligent quotient (IQ) scaled points for every 
increase in 10µg/dL of Pb
2+
 concentration in blood (Lidsky and Schneider, 2006; Bellinger, 
1995). The inverse relationship between high blood lead levels (BLLs) and decreased IQ points 
is well documented. Emergent chelation therapy is advised when BLLs reach and/or exceed 39 
µg/dL; which may have already caused irreparable IQ deficits ranging from 15-20 points (Lidsky 
and Schneider, 2006; Bellinger, 1995) depending on the initial Pb
2+ 
concentration and duration of 
exposure. Moreover, reduced IQ scores induced by Pb
2+
 poisoning are correlated with learning 
disabilities, hyperactivity, aggression, antisocial behaviors, attention deficit disorders, autism, 
hearing and speech impediments, and seizure disorders (Bellinger, 1996; Lidsky and Schneider, 
2006; Kovatsi et al, 2010; Abayzan et al, 2013). Notably, the higher the Pb
2+
 burden the more 
observable symptomatic conditions were observed. 
The body of literature on Pb
2+
 toxicity research, in both clinical and animal models, 
historically focused on alterations in adult cognitive impairment and behavioral sequelae at high 
BLLs. Silbergeld (1992) initially proposed that although Pb
2+
 poisoning causes insults to neural 
development, biological compensation ensues through as yet described mechanisms, masking 
observable cognitive and behavioral symptoms throughout youth and adolescence.  In addition, 
these  symptoms are revealed later in life by inevitable age-dependent neurodegeneration 
(Figure 1.). However, given the advancement of technologies and more sensitive measurements 
for scrutinizing behavioral methods animals will low BLL's can evince behavioral differences 
indicating that Siblergeld's (1992) model is deemed inaccurate and unspecific when explaining 
all possibilities relating to Pb
2+
 effects on early brain development. Moreover, early brain 
developmental overgrowth may contribute to masking effects of observable symptoms prior to 
synaptogenic events, equivocally substantial damage to early brain development will not be 
masked simply to brain overgrowth as they compromised functional brain mechanisms 




     
 
Figure 1. Suggested developmental timeline for unmasking Pb
2+
 symptoms as a function of age 
dependent biological compensation and neurodegeneration prior to the advancement of 
technology and more sensitive research studies [Adapted from Silbergeld (1992)]. 
 
Previously, clinical studies in children through employing neuropsychological testing 
(Lidsky and Schneider, 2006) and perturbations in animal models of postnatal development 
correlated Pb
2+
-induced impairments in sensory cortex (Wilson et al., 2000) and hippocampal 
learning and memory (Gilbert et al., 1996; Murphy and Regan, 1998). These animal models are 
used as valid model systems to investigate the underlying neurobiological consequences of Pb
2+
 
and their relationship to IQ.  Neurocognitive behaviors that regulate attention, visual-motor 
reasoning skills, social skills, mathematics, and reading skills are reported to be abnormal in 
children with BLLs lower than 10µg/dL (Canfield et al., 2003; Lanphear et al., 2000; Lanphear 
et al., 2005; Wasserman et al., 1997). Nevin (2007) used correlational models between 
individual’s preschool BLLs with concurrent rates of homicides, crimes, and tetra-ethyl lead 
gasoline exposure predicting that children chronically exposed to Pb
2+
 would have reduced IQ, 
fail out of school, become delinquent, increased risk for imprisonment and ultimately result in an 
increased government financial burden due to leaded gasoline manufacturing.  
Estimates by the United States Environmental Protection Agency (USEPA) have 
calculated that a decline in a single point of a child's IQ results in an added financial burden of 




entire population distribution leftward further increasing government financial aid of a given 
country (Godwin, 2009) (Figure 2.).  
                  
Figure 2. Simulation of governmental financial burden as a function of Pb
2+
 induced IQ 
reductions in children [Adapted from Godwin, 2009].  
 
In the United States from 1976-1980 it was estimated that 88% of children between 1-5 
years old had elevated BLLs >10µg/dL (Meyer et al., 2003). By 1997, the percentage of Pb
2+
-
exposed children dropped from 88% to 5% (Meyer et al., 2003), and 3% of Pb
2+
-exposed 
children are concentrated in low income and socially disadvantaged urban areas  (Lidsky and 
Schneider, 2003). Globally, the percent of children requiring similar supports is striking but must 






Figure 3. Comparison of elevated BLL prevalence between the US and other countries 
[Adapted from Toscano and Guilarte, (2005)]. 
 
Interpretation of data from Pb
2+
 research during the last ~60 years is complicated by the 
use of varied clinical studies with high BLLs that are rare today. The Center for Disease Control 
and Prevention (CDC) has recommended 10µg/dL (i.e. 0.48µmol/L) as the “level of concern” 
actionable intervention criteria for pediatric screenings in children (CDC, 1991). Using this 
criteria, clinical studies reveal brain alterations at levels below 10µg/dL, suggesting even this 
supposed minimum concentration is not safe (Koller et al., 2004). To further elucidate the 
molecular mechanisms underlying cognitive disruption at BLLs below 10µg/dL, various animal 
models have been used (For Review see Silbergeld and Goldberg, 1980; Jason and Kellog, 
1980).  In response to convincing clinical and animal studies of low BLL’s inducing neurological 
impairment, the CDC’s Advisory Committee on Childhood Lead Poisoning Prevention (2012) 
redacted the term “level of concern”, and are now reliant on a “reference level” of 5µg/dL (i.e. 
0.24 µmol/L) based on 97.5% of the US population of lead poisoned children in this range. 
Inconsistencies from animal studies makes it difficult to establish the effects of Pb
2+
 on  
parameters used in human subjects.  Among the inconsistencies are: a) age (Jet et al., 1997; 
Singh and Jiang, 1997; Hussain et al., 2000; Zaiser and Miletic, 2000), b) altered Pb
2+ 
kinetics in 
long term potentiation (LTP) [a model of hippocampal learning and memory consolidation]  
(Gilbert et al., 1996; Gilbert et al., 1999; Hussain et al., 2000, Liu et al., 2000; Zaiser and 
Miletic, 2000), and c) observable behavior learning deficits (Regan and Keegan, 1990; Rashidy-
Pour et al., 1995; Bourjeily and Suszkiw, 1997; Jett et al., 1997). Moreover, inconsistent dose-
dependent concentrations of Pb
2+
 have resulted in unrefined animal models (Spence et al., 1985; 
Minnema and Michaelson, 1986; Strużyñska and Rafalowska, 1994; Gilbert et al., 1999). Effects 
of Pb
2+
 on animal tissues studied in vitro are also conflicting due to both poor detection methods 
in overcoming Pb
2+
 precipitation from test solutions (Drew et al., 1989) and gender differences 
between studies (Vahter et al., 2007). Vahter et al. (2007) reported that young males are more 
susceptible for Pb
2+
 neurotoxicity in early life, whereas young females are more susceptible to 
immunotoxic effects of Pb
2+
. This suggests sex differences being differentially affected in 
response to Pb
2+
.  These findings elucidate that Pb
2+
 may disrupt specific pathways in the 







 effects on Central Nervous Tissues 
To compensate for species differences in extrapolating  lead toxicity effects that would 
most appropriately generalize to human clinical conditions. In vivo studies are advantageous as it 
permits researchers to identify the effects of Pb
2+
 in a live behaving organism with assessment of 
the Pb
2+
-induced underlying biological changes and its interaction with environment.  Such an 
approach permits the researcher with the ability to discover drug to treat the induced condition 
and to subsequently identify the pharmacotherapeutic tolerance of the organism as a bridge to 
translational biomedicine. However, in vivo studies are limited in that experimental 
manipulations during real-time physiology are less precise than methods employed in vitro. In 
vitro methods offer more careful control of manipulating neurochemical and genetic interactions 
with the complex environment of a simulated intact organism.  Notably, not all results produced 
by well controlled in vitro methods are accurately extrapolated back to a behaving organism.  
Research shifted to predominantly animal in vitro approaches to isolate central nervous 
system (CNS) tissues to investigate direct Pb
2+
 consequences on neuron populations. 
Oligodendrocytes are most vulnerable to Pb
2+
 exposure (Tang et al., 1996) and their early 
progenitors far more susceptible to Pb
2+
 disruptions than mature oligodendrocytes (Deng et al., 
2001). Suggesting fetal neurons are more vulnerable to Pb
2+
 toxicity than mature neurons. Pb
2+
-
induced delayed myelination, hypomyelination, and demyelination of neurons resulting in 
aberrant and/or absent CNS signaling (Coria et al., 1984). Within the first 2-3 years of postnatal 
development the brain undergoes massive myelination. Pb
2+
 insults during this critical stage 
generates abnormalities in CNS myelin sheaths (Dabrowska-Brouta et al., 1999) and Schwann 
cells in peripheral nervous system (PNS) (Dyck et al., 1977).  This malformation of the myelin 
sheath drastically affects brain structure and function. A major enzyme critical for myelin 
synthesis (2', 3'-cyclic-nucleotide 3'-phosphodiesterase (CNPase) has reduced activity in 
response to Pb
2+
 exposure (Dabrowska-Brouta et al., 2000).    
 Tiffany-Castiglioni et al., (1989) proposed a 'lead sink' hypothesis suggesting that Pb
2+
 
accumulates in astrocytes within the developing and mature brain, indirectly perturbing neurons. 
Astrocytic Pb
2+
 accumulation is observed in non-mitochondrial sites as a protective mechanism 
against cellular respiratory processes and surrounding vulnerable neurons (Lindahl et al., 1999). 






 sequestration, yield higher concentrations and retain these levels far after initial exposure in 
contrast to mature astrocytes (Tiffany-Castiglioni et al., 1989; 2001; Lindahl et al., 1999).  
Notably, consistent with the 'lead sink' hypothesis, Pb
2+
-storing astrocytes in early development 
may cause age-related leakage, either by increasing local Pb
2+
 concentrations or inducing focal 
Pb
2+
 lesions contributing to increased intracranial pressure, edema, and decreased brain volume 
(Cecil et al., 2008). 
Pb
2+
 has a unique function in neurons given its ability to be substituted for calcium 
(Ca
2+
), producing widespread toxic effects (Bressler and Goldstein, 1999). Studies have 





competition (Kerper and Hinkle, 1997b). Taken together, these reports 
suggest that neurons are extremely sensitive to Pb
2+
 exposure during development, and are more 
sensitive to lead than other divalent cations. This is consistent with the suggestion that there is no 
safe neurobiological concentration of Pb
2+ 
(Koller et al., 2004).   
Pb
2+
 at nanomolar concentrations competes with intracellular Ca
2+
 levels, activating 
calmodulin and in turn, stimulates protein kinase A (PKA), cyclic adenosine monophosphate 
(cAMP), phosphodiesterases, and voltage gated potassium (K
+
) channels (Bressler et al., 1999). 
Moreover, Pb
2+
 at picomolar concentrations substitutes for Ca
2+
 and increases calmodulin 
activity, whereas at high concentrations reduces calmodulin activity in neurons resulting in 
altered intracellular Ca
2+
 homeostasis (Ferguson et al., 2000; Kern and Audesirk, 2000). PKA 
activation stimulates transcription factors that regulate gene expression. Pb
2+
 may alter gene 
expression through PKA downstream of adenynyl cyclase (AC) pathways (whose downstream 
modulator is cAMP), quickly inactivating or prolonging activation through phosphodiesterases 
altering gene expression.  
Moreover, picomolar concentrations of Pb
2+
 in neurons activates protein kinase C (PKC), 
a major cellular regulator for neuronal proliferation and differentiation that is involved in 
neuroplasticity via long-term potentiation (LTP) (Bressler and Goldstein, 1991), which is more 
sensitive than nanomolar concentrations of Ca
2+
 that typically activate PKC (Bressler et a., 
1999). Markedly, hippocampal PKC expression has been shown to be reduced at 31.9µg/dL, 
consistent with the emergent chelation criteria for intervention at BLLs <39µg/dL (i.e. ~ 1.5-
1.7μM brain tissue concentration), implicating a clear correlation with increased BLLs and 




(Sun et al., 1999; Mazzonlini et al., 2001; Hussain et al., 2000).  Together these reports suggest 
Pb
2+
 competition with Ca
2+
 mishandling in neonatal and adult brains (Singh and Jiang, 1997; 
Silbergeld et al., 1980).  However, with increased focus of Pb
2+
 effects on early CNS 
developmental consequences, in vivo and in vitro, the precise molecular mechanisms occurring at 
BLLs below 10µg/dL resulting in neurological sequelae during early development remains to be 
elucidated.  
 




 enters the cell via two distinct routes: the voltage sensitive calcium channels 
(VSCCs) or the glutamatergic N-methyl-D-aspartate receptors (NMDARs); which are both 
ligand and voltage-sensitive resulting in widespread changes in gene expression through 
NMDAR Ca
2+





; which produce fast activation and slow inactivation channel 
kinetics. The activation of NMDARs require large membrane depolarizations (above 
-
50mV), as 
well as, the binding of glutamate and its co-agonist glycine to remove the magnesium (Mg
2+
) ion 
depolarization block which resides in the ion channel pore (Gallin and Greenberg, 1995).  Once 
Mg
2+




 influx increase membrane excitability and Ca
2+
-
dependent second messenger signals.  
In contrast to NMDARs, VSCCs have selectivity for only Ca
2+
 ions, but vary in their 
distinct functional membrane excitability, which is regulated by the type of VSCC activated and 
their subunit configurations. For the purposes of this work we will remain focused on the L-type 
VSCC.  Ca
2+
 enters the VSCCs with very high permeability resulting in fast activation and slow 
inactivation rates producing very large and precise localization of influx, permitting rapid and 
efficient interaction with Ca
2+
 specific second and third messenger systems. 
Calcium channels are assembled through a variety of subunit configurations exceeding 20 
different types in the human genome (Herlitze and Mark, 2005). L-Type VSCCs are comprised 







Figure 4. The L-Type VSCCs main α1 subunit and its β, δ and γ ancillary subunits.  Note that 
the β subunit is the only intracellular target of this channel in which nuclear translocation of the 
C-terminus has been reported to augment and maintain Ca
2+
 homeostasis in neurons [Adapted 
from Benarroch, (2010)]. 
 
From these arrangements, α1 is the main subunit responsible for Ca
2+
 conductance and 
bridges the ancillary subunits together forming the channel pore; whereas the remaining ancillary 
subunits (i.e. β, α2, δ and γ) are responsible for intracellular and extracellular transmembrane 
VSCC modulation. VSCC subunits encoded by Cav1.1 are expressed in skeletal muscle and 
cardiomyocytes (Hase et al., 1994; Mejia-Alvarez et al., 1994; Klugbauer et al., 2002),  The 
subunits Cav1.4  are expressed in retinal tissues and dorsal root ganglia (Morgans, 2001; Yusaf et 
al., 2001). Notably, two particular subunits encoded by Cav1.2 and Cav1.3 mRNA in brain tissue 
contributes to α1 subunits L-Type VSCC currents (Snutch et al., 1991: Williams et al., 1992).   
Of the many brain regions, L-Type VSCCs in the cortex, hippocampus, and cerebellum 
(Snutch et al., 1991; Williams et al., 1992) linking integrative dendritic and somatic signals to 
excitation transcription coupling from the membrane to nucleus. An example of this excitation 
transcription coupling would be L-Type VSCCs and cyclic AMP response element binding 
protein (CREB) phosphorylation regulating mechanisms for learning and memory through the 
mitogen activated protein kinase (MAPK) pathway (Atkins et al., 1998, Dolmetsch et al., 2001; 
Riberio et al., 2005). Consistent with these findings, spatial distribution analyses have revealed 
that L-Type VSCCs are localized to basal dendrites (Westenbroek et al., 1990) with weaker 




(GABAergic) mouse cortical neurons were observed to lack such spatial distribution patterns of 
Cav1.2 and Cav1.3 α1 subunits and instead both were localized to the proximal dendrites and soma. 
This spatial patterning of the precise location of L-Type VSCCs relative to the soma suggests a 
close interaction between the L-Type VSCC and GABAergic neurons regulating genes (See 
Figure 5.).  
 
Figure 5. The L-Type VSCCs β3 subunit autoregulation of cell excitability in early immature 
neurons. 
 
L-Type VSCCs are critical for early immature neurotransmitter release, facilitating 
specific developmental events that dictate the temporal and spatial expression patterns of Cav1.2 
and Cav1.3 mRNA. This developmental Cav1.2 and Cav1.3 mRNA expression trajectory may be 
susceptible for altered expression of the VSCC auxiliary subunits in response to Pb
2+
. 
In studies using regenerated neuromuscular junctions, L-Type VSCC antagonists increase 
evoked and inhibit spontaneous neurotransmitter release, signifying early involvement of L-Type 
VSCCs in immature acetylcholine (Ach) neurotransmitter release (Sugiura and Ko, 1997). 
Furthermore, L-Type VSCCs are localized on early migrating axons along with their growth 
cones developmentally regulating acetyl choline (Ach) release from immature neurons (Sun and 
Po, 1987; Zakharenko et al., 1999).  We hypothesize, that these findings suggest in early 
development, immature neurons in distinct brain regions may developmentally express more L-








 induced perturbations of Ca
2+
 signaling may alter spontaneous and evoked 
neurotransmitter release resulting in aberrant synaptogenesis during critical periods of neural 
development (For Review See Rice and Barone Jr., 2000); consistent with Goldstein’s (1992) 
hypothesis of Pb
2+




 competition with Ca
2+




 has been shown to compete with Ca
2+
 influx altering signal processing. In particular 
the L-type VSCCs are critical for neurotransmission, gene induction, neuronal guidance in early 
development, synaptogenesis and synaptic plasticity. Pb
2+
 mechanisms of cellular action have 
been closely linked to mimetic properties of Ca
2+
 signal activation (Audesirk and Tjalkens, 
2004). Thus, Pb
2+
 disrupts events that maintain Ca
2+
 cellular homeostasis. In particular Pb
2+
 has 
been shown to inhibit voltage-sensitive calcium channels (VSCCs) (Saliba et al., 2009), 
disrupting Ca
2+





]i), and inducing aberrant cellular depolarization (Audesirk and Tjalkens, 2004). 
Greenberg et al., (1986) discovered that neuronal excitability can regulate gene 
transcription via the binding of agonists to the nicotinic acetylcholine receptor (nAchR), which 
induced membrane depolarization and subsequent Ca
2+
 influx through VSCCs increasing c-fos 
proto-oncogene expression in neural cell lines. Interestingly, Pb
2+
 has been shown to reduce Ca
2+
 
influx through L-type VSCCs via competitive action (Büsselberg et al., 1991; Evans et al., 1991; 
Tsien et al., 1988) Thus, L-type VSCCs competition with Ca
2+
 influx  Pb
2+
 can reduce 
neurotransmission efficiency, alter membrane excitability, and essentially alter gene regulation.  
In the cytosol, Pb
2+
 influx through VSCCs may alter the phosphorylation levels of second 
messenger-activated systems such as: Ca
2+
/calmodulin-dependent kinase (CAMKII), 
Ca
2+
/calmodulin-dependent kinase-IV (CAMKIV), PKC, PKA, MAPK, and extracellular-
regulated kinases (ERK) (For Review See Toscano and Guilarte, 2005); therefore, indicating a 
complex Pb
2+
 disruption of second messenger systems causing early developmental learning and 
memory disruption.  It is noteworthy to consider that if the expression and function of L-type 
VSCCs are disrupted by Pb
2+
, then subsequent altered down-stream signaling cascades during 




patterns consistent with early theories of Pb
2+
-induced disruption of synaptogenesis proposed by 




 reduces GABA neurotransmission through inhibiting presynaptic VSCCs 
 
Of the many Pb
2+
 studies pertaining to learning and memory impairments in animals, 
glutamate systems have been the major focus (For Review See Toscano and Guilarte, 2005) due 
to the NMDARs involvement in calcium-dependent LTP as a cellular form of learning and 
memory (Bliss and Collingridge, 1993). Squire (1992) initially observed that the hippocampus is 
a fundamental brain region that regulates learning and memory, which further encodes the 
cellular properties of LTP in its intrinsic circuits.  Lasley and Gilbert (2000) suggested that Pb
2+
-
depressed LTP in hippocampus, suggesting a cellular correlation of cognitive learning 
impairments. Notably, these observations failed to report a clear mechanism within the 
hippocampal circuit responsible for explaining Pb
2+
 disruption in learning and memory. 
Moreover, these studies solely focused on glutamatergic pathways, whereas GABAergic 
interneurons provide critical synchronization of distinct neuronal rhythms between the 
hippocampus and other integrative brain structures essential for learning and memory (Soltesz 
and Deschenes, 1993; Bragin et al, 1995; Buzaki and Chrobak, 1995). Moreover, NMDARs, 
GABAARs, and VSCCs collectively drive early brain Ca
2+
 oscillations through giant depolarizing 
potentials (GDPs) to synchronize brain activity across structures; whereby they shape the timing 
and tonic phases of excitation-inhibition balancing (Ben-Ari, 2002) prior to the onset of 




              
Figure 6. Neurodevelopmental trajectory and GDP critical period illustrating GABAergic 
neurons preceding the onset of functional glutamatergic synapse formation [Adapted from Ben-
Ari et al., (2007)].  
 
When hippocampal GABAergic activity is desynchronized, the resultant effects may 
produce seizures due to improper GABA inhibition-to-glutamate excitation ratios.  These critical 
neuronal discharges balances in the hippocampus are disrupted by high BLLs (For Review See 
Lidsky and Schneider, 2003). Pb
2+
 exposure decreases the threshold for membrane 
depolarization, making neurons easily excitable, and increases hyper-excitability and potential 
seizure activity. In a case study by Healy et al., (1984) an infant with Pb
2+
 neurotoxicity suffered 
seizures associated with their poisoning, in which valproic acid was prescribed to control 
convulsive activity successfully.  Valproic acid enhances GABA synaptic transmission through 
inhibiting the enzyme responsible for breaking down GABA, GABA transaminase. Thus, 
valproic acid increased GABA neurotransmission reducing postsynaptic neuronal excitability 
and increasing seizure thresholds in this child.  
Krishnamoorthy et al., (1993) elegantly showed in rats that Pb
2+
 exposure increased 
seizure onset and induced more severe convulsions induced by selectively blocking the GABAAR 
with picrotoxin; thereby reducing GABA efficiency and increasing hyperexcitability.  Taken 
together, these studies indicate that the effects of Pb
2+




equally important with respect to learning, memory, and seizure susceptibility as are the 
glutamatergic systems. However, the GABAergic system must be carefully considered due to its 
synapse formation arising prior to glutamatergic systems in early development.  
To further support the claim that Pb
2+
 inhibits GABA neurotransmission, nerve terminal 
preparation studies, otherwise known as synaptosomes, have been widely used to focus solely on 
transynaptic communication.  Ca
2+
 influx through VSCC regulates the liberation of 
neurotransmitters from presynaptic nerve terminals (Turner et al., 1993). In synaptosomal 
preparations, Pb
2+
 enters isolated nerve terminals and is further sequestered in mitochondria 
(Silbergeld et al., 1977). Previously, Regunathan and Sundaresan, (1985) conducted 
synaptosomal studies under Pb
2+
 treatments and observed reduced postsynaptic glutamate 
binding and presynaptic uptake from rat cortex, cerebellum, and brainstem.  
Jablonska et al., (1994) showed that chronically Pb
2+
-treated rats have decreased GABA 
uptake, increased dopamine uptake that were independent of Ca
2+
 concentrations, with 
morphological changes in the synaptic vesicles and mitochondria. Pb
2+
 has been shown to induce 
biphasic properties where it inhibits depolarization-evoked release (i.e. increasing the neurons 
threshold to fire specific chemical signals) and increases spontaneous release (i.e. increasing 
non-specific neurotrophic factors and neurotransmitters) from rat hippocampal synaptosomes 
(Minnema et al., 1988). These biphasic properties have shown that low concentrations of Pb
2+
 
increases spontaneous neurotransmitter release and block depolarization dependent 
neurotransmitter release across transmitter systems (Goldstein, 1980).  
To further elucidate Pb
2+
 toxicity and the relationship between glutamate/GABA-
glutamine cycles with respect to neuronal-astrocyte excitability, synaptosomal studies 
investigated GABA binding release and uptake. Neurons cannot synthesize glutamate or GABA 
from glutamate decarboxylase (GAD) and must rely on astrocyte uptake through transport 
proteins to convert these neurotransmitters into glutamine via catabolism of GABA transaminase 
and succinate-semialdehyde dehydrogenase. Strużyñska and Sulkowski, (2004) showed 
diminished GABA transport, decreased uptake and depolarization evoked release, lower 
expression of GAD, the GABA synthesizing enzyme, and over expression of the GABA 
transport protein GAT-1. Their work implicates another supporting argument for Tiffany-
Castiglioni’s (1989) 'lead sink' hypothesis, that Pb
2+
 may disrupt both glutamate and GABA 




Astroglia are critical for glutamate/GABA-glutamine metabolism and Pb
2+
 disruption of this 
pathway as may result in cognitive impairments and seizure susceptibility.  Importantly, 
Strużyñska and Sulkowski, (2004) used only rat forebrain preparations, which may not 
generalize towards region specific differences, but should be interpreted with caution.  Spence et 
al., (1985) showed that acute Pb
2+
 exposure reduced KCl dose-dependent GABA release from 
spinal cord synaptosomal preparations. Pb
2+
 inhibition of GABA release from synaptosomes 
(Minnema and Michaelson, 1986; Strużyñska and Rafalowska, 1994) and GABAergic 
hippocampal neurons in culture (Braga et al., 1999) were also reported. In chronic Pb
2+
 treated 
synaptosomes, GABA release was altered as a function of dose and duration (Minnema and 
Michaelson, 1986; Strużyñska and Sulkowski, 2004; Lasley et al., 1999; Lasley and Gilbert, 
2002).  
Borisova et al., (2011) proposed that presynaptic disturbances induced by Pb
2+
 may cause 
partial dissipation of the synaptic vesicle proton gradient resulting in decreased VSCC dependent 
neurotransmitter release, incomplete vesicle filling with transmitter substances, and inhibition of 
the Na
+
-dependent glutamate transporter. These results may also explain the increase in 
spontaneous neurotransmitter release under Pb
2+
 exposure. VSCC inhibition has been well 
documented as the best reported mechanism for presynaptic inhibition (Giustizieri et al., 2005). 
Xiao et al., (2006) has shown that Pb
2+
 induces direct inhibition of VSCC in developing 
hippocampal slices attenuating action potential dependent GABA release as a more precise 
mechanism for Pb
2+
 neurotoxic cognitive impairments in early development.    
 
1.6-The GABA shift is developmentally regulated by the Ca
2+
-dependent gene induction 
of the KCC2-cotransporter 
The GABA shift is defined as the developmentally regulated switch between early 
immature neurons responding to GABA neurotransmission with excitation-to-mature neurons 
responding to GABA neurotransmission with inhibition (Ben-Ari, 2002). There are two Ca
2+
-
dependent inducible Slc genes (i.e. solute carries that transport molecules across the cell 















cotransporter (KCC2). These genes arise from a family of electroneutral cation-chloride 




This gene family is responsible for maintaining cell volume regulation, epithelial transport, and 
GABAergic circuitry (Kahle et al., 2010). The latter sets the stage for appropriate GABAergic 
and glutamatergic regulation of neural development in organisms.  
In the mature brain the two major neurotransmitters, GABA and glutamate, mediate a 
balance between excitation and inhibition of neuronal networks, respectively. However, in the 
immature brain the GABAergic system is initially excitatory and precedes the subsequent 
functional excitatory activity of the glutamatergic system due to a large chloride [Cl
-
]i when 
compared to the [Cl
-




Figure 7.  The Cl
-
 concentration and electrochemical gradients that maintain early GABAergic 
excitation and mature inhibition based on the NKCC1 and KCC2 Cl
- 
transport proteins [Adapted 
from Ben-Ari et al., (2007)]. 
 
Therefore, presynaptic GABA secreting neurons can excite immature post synaptic 
neurons expressing GABAAR’s, as long as the threshold is below ECl- and the driving force of Cl
-
 
remains at higher intracellular concentrations. This critical developmental process is regulated by 
synergistic activity between VSCC and GABAAR’s. Ca
2+
 influx through VSCCs depolarize 
neurons, activate GABA receptor permitting the efflux of Cl
-




evidencing synergistic activity between VSCCs and GABAAR’s  Following VSCC and GABAAR 
synergistic action, GABA neurotransmission excites post synaptic cells, in turn, activating 
NMDARs. NMDARs facilitate synchronized activity between the Ca
2+
 wave oscillations and 
GDPs; which have been identified as the hallmark principle for developing neuronal networks 
(Ben-Ari, 2002). The major regulators of the GABA excitation-to- inhibition shift are the KCC2 
cotransporters. The shift is a Ca
2+
-mediated process in which KCC2 cotransporters are expressed 
as a result of VSCC activation secondary to GABA-mediated depolarizations (Ben-Ari, 2002). 
Thus, it is prudent to evaluate Pb
2+
 effects on KCC2 expression during the GABA shift in early 
development. 
The developmental shift in GABA from excitation in immature neurons to inhibition 
when neurons mature, are developmentally regulated by the expression levels of NKCC1 and 
KCC2 (Sun et al., 2010) and their subsequent functional activity. In early development NKCC1 
cotransporters are highly expressed and very active, while the KCC2 cotransporters have a 
relatively low expression level and are primarily inactive (Gamba, 2005).  As the immature 
neurons are releasing spontaneous GABA to remain viable and functional they also maintain 
their cued guidance via neurotrophic factors in conjunction with long-range secretions by their 
target cells. Once these immature neurons are fully guided to their fate destination they begin to 
signal GDPs which allow higher conductances of Ca
2+
 influx due to the cooperativity from the 
initially inactivated α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor (AMPARs) 
and NMDARs.  
To further evidence the KCC2 cotransporters regulating the GABA shift, studies in 
culture evaluated excitatory GABAergic cells that were injected with KCC2 cotransporter 
mRNA. The results indicated a shift from GABA excitation-to-inhibition in response to the 
increase in KCC2 expression. The shift was determined to be a GABA mediated process in 
which KCC2 cotransporter responded with feedback to the GABAARs (Ben-Ari, 2002). 
Interestingly, when immature neurons were exposed to GABAAR antagonists the GABA shift 
was prevented, but resulted in a peculiar effect in that KCC2 cotransporters were not affected 
(Ben-Ari, 2002). Therefore, the KCC2 cotransporter activity and its expression in relation to 
brain maturation remain to be elucidated. This indicates that the KCC2 cotransporter activity 






 at nanomolar concentrations (Bressler et al., 1999) prematurely establishing 




 alters immediate-early gene induction via the L-type VSCC 
VSCCs maintain their precise spatio-temporal expression and signal functions through 
principally conserved biophysical properties: (a) they are highly voltage dependent allowing for 
rapid activation and inactivation of the channel pore which permits Ca
2+
 influx in response to 
changes in membrane potential, (b) they are highly permeable to Ca
2+
 in contrast to other 
potential ions, (c) VSCCs must be localized in areas on neurons where they can easily access 
relevant regulatory targets of Ca
2+
-dependent signaling cascades; thus allowing for rapid 
localized increases in [Ca
2+
]i, (d) lastly, they must undergo modulation and diverse 




 can influx into the cytosol in bovine adrenal medullary cells through L-
type VSCCs (Sun and Suszkiw, 1995; Simons and Pocok, 1987). Once Pb
2+
 invades the 
intracellular cytosol it is able to perturb L-type VSCCs kinetics by increasing ICa through 
attenuation of the calcium-dependent steady state inactivation of the L-type VSCCs (Sun and 




 conductance, the subsequent 
increase in [Ca
2+
]i results in rapid and prolonged second messenger system activation, and 
ultimately third messenger gene induction affecting an array of regulatory protein transcription 
factors such as CREB (Toscano et al., 2003; Toscano et al., 2002), NR1 (Toscano and Guilarte, 
2003; Nihei and Guilarte, 1999; Guilarte and McGlothan, 1998), c-fos and jun (Toscano and 
Guilarte, 2005; Finkelstein, Markowitz, Rosen, 1998), and brain derived neurotrophic factor 
(BDNF) (Schneider et al., 2001); all of which resulted in altered mRNA expression levels for 
each of these target genes in response to Pb
2+
 exposure. In addition, internal endoplasmic 
reticulum stored of Pb
2+
 may be released into the cytosol activating second messenger systems 
altering gene activity; otherwise, cytosolic Pb
2+
 can activate hormonally regulated G-proteins 
that stimulate VSCC activity (Nussey and Whitehead, 2001).   
More recently, Schneider et al., (2011) investigated the effects of a 30-day postnatal Pb
2+
 
diet in the rat and changes in hippocampal gene expression via microarray analyses.  They found 
that Pb
2+




calcium binding domain (Efcab1), had a significant10-fold increase in response to Pb
2+
 
treatment, whereas females exhibited a significant 0.6-fold reduction in hippocampal gene 
expression (Schneider et al., 2011).  Ca
2+
 signaling can be either indirectly activated by Ca
2+
-
dependent kinases and phosphatases regulating transactivating properties of transcription factors 
(Dolmetsch et al., 2001 West et al., 2001; Kornhauser et al., 2002; Spotts et al., 2002) or directly 
via nuclear Ca
2+
 sensors (Leclerc et al., 2012). 
Currently, a Ca
2+-
dependent DNA regulating transcription factor is the downstream 
regulatory element antagonist modulator (DREAM); derived from the recoverin 4-EF hand 
subfamily, involved in transcription repression (Carrion et al., 1999; Mellstrom and Naranjo, 
2001). Moreover, a unique concept for VSCCs arose, whereby the Ca
2+
 domains may act in a 
functional way as a self regulating transcription factor, such as the Cav1.2 C-terminal fragments; 
otherwise known as the Ca
2+
-channel associated transcriptional regulator (CCAT) (Gomez-
Ospina et al., 2006). The CCAT has been shown to translocate to the nucleus, regulate gene 
expression, and increase dendritic arborization once activated (Gomez-Ospina et al., 2006). 
Schneider et al., (2011) identified 175 genes that were differentially regulated in response to Pb
2+
 
and gender further altered expression patterns, which may have resulted from Pb
2+
 alterations in 
CCAT regulation. NMDAR2A mRNA in the developing hippocampus of gestational Pb
2+
 treated 
rats (Nihei and Guilarte, 1999), and mRNA NR1 splice variants were reported to variably alter 
hippocampal expression in all cornu ammonis (CA) regions when compared to controls in 
response to gestation and developmental Pb
2+
 exposure evidencing altered synaptogenesis 
(Averil et al., 1980; McCauley et al., 1982; Kawamoto et al., 1984; ) and negatively effecting 
learning in these rats (Guilarte et al., 2000; Guilarte and McGlothan, 2003).  
In primary neuronal cultures, treatment with Pb
2+
 (10µM-100µM) inhibits NMDAR 
activity during the critical stage of synaptogenesis resulting in altered glutamatergic connectivity 
later in life (Neal et al., 2011). These data may indicate that alteration in the glutamatergic 
system induced by lead may result in aberrant connectivity in the brain. Despite the importance 
of Ca
2+
 channels being localized near NMDAR in cells and their synergistic actions in learning 
and memory, NMDARs during early development are present but inactive leaving only 
GABAARs and VSCCs as mediators of excitation.  Not until the GABA shift is completed in 
early development do the NMDARs take on a sequential role in regulating Ca
2+




synchronize GDPs as the molecular substrate for initially hard wiring the brain and subsequently 
establishing the networks for experience dependent learning and memory.  
Given this information it is prudent to evaluate the potential for Pb
2+
 to alter the 
expression of genes critical in early GABA development prior to the activation of the NMDARs 
and the establishment of functional neuronal circuits. Here, we hypothesize that in response to 
gestational Pb
2+
 exposure in the rat the Slc12a family genes that regulate the timed expression of 
the NKCC1- and KCC2-transporters are disrupted. These transporters regulate the 
developmental changes in GABAergic excitation-to-inhibition.  Therefore, alteration in the 
expression pattern would interfere with critical periods of brain development. The potential for 
aberrant synaptic connections prior to the NMDAR system being activated would suggest that not 
only are glutamatergic neurons susceptible to Pb
2+
 insult, but GABAergic neurons may be 
equally affected prior to glutamatergic neurons. However, given the importance of the GABA 
system in early neural development, it may be more informative in elucidating the molecular 
mechanisms of Pb
2+
 action on the GABAergic neural development. 
Studies by Murphy et al., (1991) and Deisseroth et al., (1996) showed that in the presence 
of pharmacological agents that block L-type VSCCs, inhibition of immediate-early gene inducers 
occurs. Therefore, the influx of Ca
2+
 is responsible for immediate-early gene induction, 
indicating that any disruption of this signaling pathway, such as those produced by Pb
2+
, may 
result in altered immediate-early gene induction consistent with published data (Schneider et al., 
2011).  
The findings from the aforementioned studies in accordance to our hypothesis suggest the 
following signaling cascade of Pb
2+
 resulting in altered gene induction during early development 





Figure 8. Hypothesis Model Pb
2+ 
Competition Through VSSCs Reduces β3 Subunit 





 may compete with Ca
2+
 influx through the L-type VSCCs; 2) intracellular Pb
2+
 
may increase the ICa through VSCCs by delaying its ability to inactivate the channel; 3) increased 
[Ca
2+
]i in response to Pb
2+
 may alter the activity of gene induction pathways through a) sustained 
Ca
2+
-dependent activity with second messengers or alternatively b) Pb
2+
 may directly activate 
third messengers altering DNA; and 4) Pb
2+
 may alter transcription factors of the VSCCs as a 
self-regulating mechanism in response to Pb
2+
 exposure. The VSCCs-β3 subunit (CCAT) upon 
neuronal excitation, translocates from the membrane to the nucleus and transcribes mRNA 
coding from the VSCCs gene CACNB β3 (Bros et al., 2011; Satin, et al., 2011).  
Thus, this signaling serves as an autoregulatory process in neurons through a distinct C-
terminal encoding of a VSCCs-β3 subunit transcription factor in response neuronal excitability 
(Gomez-Ospina et al., 2006). Moreover, VSCCs-β3 activity increases as a function of post natal 
development and is highly expressed in GABAergic neurons in early development (Gomez-
Ospina et al., 2006). Thus, Pb
2+
 may disrupt this VSCCs-β3 autoregulation, resulting in altered 
gene transcription, decreased Ca
2+
 signaling, and altering neurite formations and extensions 





1.8-Postulated molecular mechanism of Pb
2+
 perturbation of GABAergic immediate-
early gene induction via the L-type VSCC and reduced GABA release during 
synaptogenesis. 
The goal of this study was to investigate how chronic gestational Pb
2+
 exposure leads to a 
neurodevelopmental delay in the rat model through a multi level system approach using 
molecular, cellular, physiological and behavior analyses described as follows.  
 
 We hypothesized that Pb2+, through competition with initial Ca2+ influx and inhibition of 
Ca
2+
-dependent processes, leads to premature increased expression of key regulatory 
proteins directing the GABA shift resulting in premature wiring of neuronal circuits. To 
evaluate this primary cerebellar neuronal cultures from harvested from postnatal day 6 
rats were used as an in vitro model system. Chronic gestational Pb
2+
 exposure may 
significantly alter the Ca
2+
-dependent activity and autoregulatory transcription and 
translation of the VSCCs β-3 subunit expression resulting in perturbations in GABAergic 
signaling and GDP-induced neuronal network miss-wiring and de-synchronization with 
altered synaptogenesis in early development.  We sought to evaluate the presences of 
VSCC β-3 subunit nuclear translocation and relative GABAAR expression in cultured 
cerebellar neurons to test our hypothesis. We hypothesize that Pb
2+
 attenuation of 
VSCC's in early development produces an upregulation in CACNB β3 mRNA expression 
channelopathies and a down regulation of GABAARs β-3 chain mRNA expression, which 
is associated with neurodevelopmental disorders such as schizophrenia and autism (Hyde 
et al., 2011; Khale et al., 2008). In order to assess these changes we sought to 
characterize the altered mRNA expression of the KCC2 transporter, which is responsible 
for shifting from GABA excitation-to-inhibition, mRNA for GAD isoforms GAD80, 
GAD86 (i.e. as markers for early excitatory GABAergic events) GAD65, and GAD67 (i.e. 
as markers for mature inhibitory GABAergic events),  NKCC1 (i.e. a marker for early Cl
-
 
importers regulating GABAergic excitation), KCC2 (i.e. a marker for late Cl
-
 exporters 
regulating GABAergic inhibition), GABAAR β-3 (i.e. a GABAergic marker for inhibitory 
regulation of fear learning and memory and a susceptibility marker for autism 
neuropathology), CACNB β3 (i.e. a marker for L-Type VSCCs β-3 subunits to assess 








 We predict that the effects of Pb2+ on these genes are age- and brain region-dependent. 
We will investigate the Pb
2+
-induced changes in the whole frontal cortex and 
hippocampus to assess the spatial and temporal distribution of CACNB β3  and GABAAR 
β-3  across development. 
 We postulate that the aforementioned altered molecular mechanisms of action in response 
to Pb
2+
 neurotoxicity may result in enhanced brain excitability resulting in increased 
spontaneous neurotransmitter release during early development, attenuation of evoked 
neurotransmitter release, disrupted synaptic activity with respect to presynaptic vesicle 
liberation and post synaptic modification impairing early synaptogenesis. We hypothesize 
that gestational Pb
2+
 exposure will produce alterations in spontaneous and evoked 
neurotransmitter release, transmitter uptake, and postsynaptic binding of transmitter 
substances.  
 Consistent with these disruptions in age-dependent frontal cortex and hippocampal brain 
plasticity induced by gestational Pb
2+
 exposure aberrations in experience dependent 
learning and memory, negative effects on emotionality and disruption in reversal and/or 
inhibitory learning (i.e. either by prefrontal cortical disinhibition or over excitation) 
(Burtkowski, 1964) behavioral consequences are expected. In addition, we will assess the 
potential recovery on Pb
2+
 induced disruptions by GABAergic agonists as a potential 
pharmacotherapeutic intervention for Pb
2+
 toxicity. Together the aforementioned effects 
may help explain the initial stages of Pb
2+
 induced perturbations of early GABAergic 
development prior to the onset of the AMPARs and NMDARs role in learning and 
memory. 
 
The delicate interplay between both the GABAARs and VSCCs when challenged by chronic 
gestational low level Pb
2+
 exposure do not result in organism death.  Thus, biochemical 
compensations exist in response to this Pb
2+
 neurotoxicity that, in turn, produces altered brain 













 Long-Evans Norwegian hooded male and female rats were paired. Control rats were fed a 
regular Purina rat chow (Dyets Inc. # 61212) [containing 970gm/Kg Purina RMH 1000 chow, 
30gm/Kg maltose dextrin], while the pairings for Pb
2+
 rats were fed a diet containing 1.5g/Kg 
lead acetate (Dyets Inc. # 612113) [containing 968.4gm/Kg Purina RMH 1000 chow, 30gm/Kg 
maltose dextrin, 1.5gm/Kg lead acetate, and 0.1gm/Kg yellow dye] (956ppm) ad libitium from 
pairing throughout gestation and continued through parturition and weaning at 21 days of age.. 
At postnatal day (PND) 2, 7, 14, and 22 rats (N = 5) were anesthetized with 50mg/kg Nembutal® 
i.p., transcardial blood samples were collected, then rats were sacrificed and whole brains were 
taken in accordance with The College of Staten Island (CUNY) IACUC approval. Dams of the 
pups (n = 3) were also sacrificed at the same time to track whether or not BLL concentrations 
changed as a function of age and/or their relationship to the mother’s level of Pb
2+
 toxicity. 
Additionally, rat brains were harvested, Cryoprotected (or homogenized) and stored at
 -
80ºC for 
further processing of proteins. 
 
 2.1.2-Blood lead level analyses 
 
 At the point of animal sacrifice transcardial blood samples were collected in 
ethylenediaminetetraacetic acid (EDTA) coated S-Monovette® syringes (Sarstedt, Germany) 
mixed and immediately frozen on dry ice.  Samples were then sent out for BLL determination to 
Magellan Diagnostics (North Bellirica, MA). BLLs were determined using atomic absorption 








 2.1.3.-Statistical analyses 
 
 All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK).  An Age X Subject 
and an Age X Treatment ANOVA were used to identify factor and interaction effects.  Significant 
differences were determined by an equal N Tukey’s HSD post hoc comparison test. Significance 
levels were set at p < 0.05 with a SEM of 95%. Data are presented as mean ± SEM. 
 
 2.2.-Results  
 
                










































Figure 9. Dams and pups BLL subject comparisons as a function of age. Pups at PND 2 had 
increased BLLs when compared to their dams.  Following PND 2 a reversal of BLL profiles 





           














































Figure 10. BLL treatment comparisons as a function of age during development. Control rats 
were Pb
2+
 negative throughout development.  There was a significant difference in Pb
2+
 treated 
rats in all ages when compared to controls (p<0.001***). Pb
2+
 treated rats showed significant 
differences at PND 7 (p<0.001***) and 14 (p<0.001***) when compared to PND 2 rats. In 
addition, the Pb
2+
 rats showed an inverted curvilinear relationship in elevated BLLs at PND 2 
and 22, suggesting a difference in absorption from early lactation feeding, relative rat blood 
volume and ability to independently feed from the food cages at PND 22.  
 
 The influence of a 956ppm Pb
2+
 gestational diet (i.e. from birth to sacrifice) resulted in 
pup mean blood lead levels (BLLs measured in μg/dL) at PND 2= 41.83 SEM± 14.17, PND 7= 
34 SEM± 10.4, PND 14= 30.17 SEM± 7.77 and PND 22= 38.67 SEM±10.67. The dams at 
corresponding Pb
2+
 exposure times evinced mean BLLs at PND 2= 37 SEM± 9, PND 7= 41.33 
SEM± 21.33, PND 14= 39.33 SEM± 60.33 and PND 22= 43.6 SEM± 22.3 respectively.  
 In contrast, control pups and dams were Pb
2+
 negative.BLL samples revealed an Age 
effect (DF=3, MS=66.81, F=4.128, p<0.01**) and Subject effect (i.e. Dam or pup) (DF=1, 
MS=147.62, F=9.121, p<0.01**) (See Figure. 9.). Moreover, an Age X Subject interaction was 
observed (DF=3, MS=77.88, F=4.8, p<0.01**) (See Figure 9.). Figure 10. shows the 
differences in BLLs based on treatment conditions having an Age effect (DF=3, MS=79.06, 
F=14.708, p<0.001***) a Treatment effect (DF=1, MS=14,840.33, F=2,760.99, p<0.001***) and 







 Figure 9. shows that at PND 2 pups had an elevated BLL (~ 42μg/dL) in contrast to their 
dams (~ 37μg/dL) and at PND 7 these observations reversed in that the dam had elevated BLLs 
(~42μg/dL) when compared to their pups, whose BLL dropped remarkably (~34μg/dL).  These 
reversed BLLs/age ratios persisted throughout postnatal development (PND 7-14), whereas at 
weaning (PND 22) pups BLLs were quite similar (~ 39μg/dL) to that of their respective dams 
(~43μg/dL). These results suggest that rat pups were vulnerable to Pb
2+
 exposure and 
accumulated more Pb
2+
 at PND 2 during critical stages in early development.  Notably, at PND 7 
there was a decrease in pup BLLs, which may be due to either increased excretion, but was more 
likely due to brain/body deposition. If early brain Pb
2+
 deposition was highest at PND 7 it would 
suggest that this age in postnatal development may contribute considerably to altering the critical 
periods in early brain development and further disrupt fine tuning and wiring during 
synaptogenesis at PND 14. Lastly, the decrease in BLLs from PND 2 through 14 and increase in 
BLLs from PND 14 to 22 could be explained by the rats’ respective weight to blood volume ratio 
as a function of age and the pups independence of eating leaded food (See Figure. 9.).  In 
addition, at PND 2 the Dams milk is more concentrated and may contain more Pb
2+
 that is 
readily absorbed when compared to later postnatal ages. Figure 10. illustrates that there were no 
BLL concentrations detected above or below the 1µg/dL range in control rats irrespective of age.  
Notably, the rats exposed to Pb
2+
 showed significant body burdens with highest levels at PND 2 














 exposure alters Ca
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-dependent GABA shift: Novel mechanism for early Pb
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 Experimentally naïve male Long Evans Norwegian Hooded rats (Taconic, N.J.) (Control 
n = 12; Pb
2+
 n = 12; n = 3 for PND 2, 7, 14, and 22) were maintained under controlled 
temperature (24 ± 1°C) and humidity (55 ± 5%), on a 12-hr light (17:00–7:00 hr):12-hr dark 
(7:00–17:00 hr) cycle.  Lead was administered as described in section 2.1.1. Age-matched 
controls were used as a reference group.  
 
 3.1.2-Sample preparation 
 
 At PNDs 2, 7, 14, and 22 rats were selected from each treatment condition (i.e. N = 3) for 
brain extraction of both frontal cortices and hippocampi respectively. Briefly, rats were 
anesthetized with Nembutal
®
 (i.p. injection 50mg/Kg) and sacrificed in accordance with The 
College of Staten Island’s IACUC approval procedures.  Their frontal cortices and hippocampi 
were homogenized and phenol: chloroform extracted in less than 2 minutes and frozen on at
 -
80ºC until use.  
 
 3.1.3-RNA preparation 
 
 RNA was prepared from brain tissue samples in accordance with manufactures’ protocol 
(TRIzol Reagent; Invitrogen 15596-026). Briefly, 50-60mg of wet brain tissues were weighed 
and homogenized in 1ml of TRIzol regent per 100mg of tissue using a glass-Teflon for 1 hr. Post 
centrifugation, RNA was subjected to a chloroform extraction and subsequently precipitated with 






 3.1.4-Preparation of cDNA and real-time PCR analysis 
 Identical amounts of total RNA (i.e. 10µg) were treated with RNase-free DNase (Qiagen 
cat. #79254) at 37°C for 1 hr and purified by phenol/chloroform extraction (i.e. 3:1) followed by 
an ethanol precipitation. From the purified RNA, 1µg was used in the SYBR GreenER Two-Step 
qRT-PCR kit (Invitrogen cat. #11765-100) for the first strand cDNA synthesis and in the real-
time PCR reaction preparation according to the manufactures protocol. The real-time PCR 
primers are noted in Table 1. All experiments were repeated three times. In addition, within each 
experiment PCR reactions were done in triplicates and analyses conducted through a 7500 
sequence detection system (Applied Biosystems).    
 
Table 1. Oligonucleotides used in the real-time qRT-PCR reactions. 
GAPDH ORF                      
      Forward primer            5’-ACAGGGTGGTGGACCTCATG-3’ 
      Reverse primer             5’-GTTGGGATAGGGCCTCTCTTG-3’ 
GAD 80 ORF 
      Forward primer            5’-AGTGTGGCCTCCAGAGGTTC-3’ 
      Reverse primer             5’-TGGATATGGCTCCCCCAGGAG-3’ 
GAD 86 ORF 
      Forward primer            5’-TGGCCTCCAGAGGTGATGGT -3’ 
      Reverse primer             5’-TGGATATGGCTCCCCCAGGAG -3’ 
GAD 65 ORF 
      Forward primer           5’-GGCTCTGGCTTTTGGTCCTTC -3’ 
      Reverse primer            5’-TGCCAATTCCCAATTATACTCTTGA -3’ 
GAD 67 ORF 
      Forward primer           5’-GCTGGAAGGCATGGAAGGTTTTA-3’ 
      Reverse primer           5’-AATATCCCATCACCATCTTTATTTGACC -3’ 
GABAA β3 ORF 
      Forward primer          5’-CCACGGAGTGACAGTGAAAA-3’ 
      Reverse primer           5’-CACGCTGCTGTCGTAGTGAT-3’ 
CACNB β3 ORF 




      Reverse primer           5’-CACGCTGCTCGTAGTGAT-3’ 
NKCC1 ORF 
      Forward primer          5’-ATGAGTCTTCCAGTTGCCCG-3’ 
      Reverse primer           5’-GCAACGTGTCCATGTGCTTT-3’ 
KCC2 ORF 
      Forward primer          5’-GGACCCCCGCATACAAAGAA-3’ 
      Reverse primer           5’-CCTCCAGACCTTGTGGTGAC-3’ 
MECP2ORF 
      Forward primer          5’-CAGGTCATGGTGATCAAACG -3’ 
      Reverse primer           5’-CCACACTCCCAGGCTTTCTA-3’ 
FMR1ORF 
      Forward primer          5’-GTGAGATTCCCACCACCTGT -3’ 
      Reverse primer           5’-CCAACAGCAAGGCTCTTTTT -3’ 
 
 
 3.1.5-Target DNA sequence estimations 
 
 Target DNA sequence quantities were estimated using the procedures described by 
Andrew et al., (2012); Ford et al., (2007); Wimalarathna et al., (2011), and Zhang et al., (2009). 
Briefly, the target DNA sequence quantities were estimated from the threshold amplification 
cycle number (CT) using Sequence Detection System Software (Applied Biosystems). A ΔCT 
value was obtained by subtracting the respective primer CT value from the CT value from the 
corresponding glyceraldehyde 3-phosphate dehydrogenase (GAPDH) value in order to 
normalize the differences in cDNA aliquots as a house keeping gene. Therefore, the relative 
mRNA levels were expressed as 2
(-Δ CT) 
X 100% of GAPDH and data transformed to a Log10 









 3.1.6-Statistical analyses 
 
 All data were transformed from the relative mRNA 2
(-Δ CT) 
X 100% of GAPDH to a 
Log10 value to easily compare differences in fold expression. Data were then further analyzed in 
Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK).  An Age X Treatment X Gene ANOVA was used to 
identify factor and interaction effects.  Significant differences were determined by either an equal 
or unequal N Tukey’s HSD post hoc comparisons test. Significance levels were set at p < 0.05 




























    
        
Figure 11. Chronic gestational Pb
2+
 exposure down regulated Caβ3 mRNA expression in cortex 
and hippocampus during early brain development.  Cortical Caβ3 mRNA was down regulated 
from PND 7 through PND22 (p<0.001***) (A). Hippocampal Caβ3 mRNA was down regulated 
affected at PND 7 and 22 (p<0.001***), but recovered at PND 14 (B). GABA β3 mRNA was 







 Figure 11. GABAAR’s showed that in cortex GABAAR-β3 and Ca β3 mRNA expression 
changes induced by Pb
2+
 exposure caused a Gene effect (DF=1, MS=2.31, F=82.69, 
p<0.001***) an Age effect (DF=3, MS=1.76, F=63.15, p<0.001***), a Gene X Age Interaction 
(DF=3, MS=0.36, F=12.93, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.769, 
F=27.55, p<0.001***) and a Gene X Age X Treatment interaction (DF=3, MS=0.21127, 
F=7.565, p<0.001***) (A). 
 Figure 11. showed that in hippocampus GABAAR-β3 and Ca β3 mRNA expression 
changes induced by Pb
2+
 exposure caused an Age effect (DF=3, MS=0.837, F=5.56, p<0.01**), a 
Treatment effect (DF=1, MS=1.129, F=7.50, p<0.01**) a Gene effect (DF=3, MS=29.00, 
F=192.58, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.96, F=6.35, 
p<0.001***), an Age X Gene interaction (DF=9, MS=0.47, F=3.13, p<0.001***), a Treatment X 
Gene interaction (DF=3, MS=0.68, F=4.53, p<0.006166) and an Age X Treatment X Gene 









            
            
Figure 12. Chronic gestational Pb
2+
 exposure decreases KCC2 and increases NKCC1 mRNA in 
cortex and hippocampus during early brain development.  Cortical KCC2 mRNA is down 
regulated from PND 7 (p<0.05*), through PND 14 (p<0.001***), whereas NKCC1 mRNA is up 
regulated at PND 2 and 7 (A). Interestingly, in hippocampus the KCC2 mRNA is down regulated 
at PND 2 through 7 (p<0.001***) and up regulated at PND 14 (p<0.05*), whereas NKCC1 





 Figure 12 showed that in cortex NKCC1 and KCC2 mRNA expression changes were 
altered by Pb
2+
 exposure resulting in an Age effect (DF=3, MS=1.76, F=63.15, p<0.001***), a 
Gene effect (DF=1, MS=2.31, F=82.69, p<0.001***), an Age X Treatment interaction (DF=3, 
MS=0.77, F=27.55, p<0.001***), an Age X Gene interaction (DF=3, MS=0.36, F=12.93, 
p<0.001***) and an Age X Treatment X Gene interaction (DF=3, MS=0.21, F=7.57, 
p<0.001***) (A).  
 Figure 12 showed that in hippocampus NKCC1 and KCC2 mRNA expression changes 
were altered by Pb
2+
 exposure resulting in an Age effect (DF=3. MS= 1.43, F=17.86, 
p<0.001***), a Treatment effect (DF=1, MS=4.22, F=52.68, p<0.001***), a Gene effect (DF=1, 












        
         
Figure 13. Chronic gestational Pb
2+
 altered early and late GAD mRNA expression levels. 
Cortical Pb
2+
 exposure disrupted early GAD 80 and 86 and late GAD 67 mRNA expression at 
PND 2 (p<0.01**) and altered late GAD 65 and 67 mRNA at PND 22 (p<0.001***) (A). 
Hippocampal, early GAD 86 mRNA expression was up regulated at PND 2 (p<0.01**) and late 





 Figure 13. showed that in cortex early GAD 80 and 86 and late GAD 65 and 67 were 
perturbed by Pb
2+
 resulting in an Age effect (DF=3, MS=3.11, F=34.66, p<0.001***), a Gene 
effect (DF=3, MS=29.61, F=330.35, p<0.001***), an Age X Treatment interaction (DF=3, 
MS=1.34, F=14.95, p<0.001***), an Age X Gene interaction (DF=9, MS=0.79, F=6.58, 
p<0.001***), a Treatment X Gene interaction (DF=3, MS=0.59, F=6.58, p<0.001***) and an 
Age X Treatment X Gene interaction (DF=9, MS=0.50, F=5.56, p<0.001***) (A). 
 Figure 13. showed that in hippocampus early GAD 80 and 86 and late GAD 65 and 67 
were perturbed by Pb
2+
 resulting in an Age Effect (DF=3, MS=0.84, F=5.56, p<0.01**), a 
Treatment effect (DF=1, MS=1.13, F=7.50, p<0.01**), a Gene effect (DF=3, MS=29.00, 
F=192.57, p<0.001***), an Age X Treatment interaction (DF=3, MS=0.96, F=6.35, 
p<0.001***), an Age X Gene interaction (DF=9, MS=0.47, F=3.13, p<0.001***), a Treatment X 
Gene interaction (DF=3, MS=0.68, F=4.53, p<0.01**) and an Age X Treatment X Gene 










               
                
Figure 14. Chronic gestational Pb
2+
 effects on synaptic vesicle release MECP2 and synaptic 
plasticity FMR1 mRNA expression levels. Pb
2+
 up regulated FMR1 mRNA expression levels at 
PND 2 through 7 (p<0.001***) and down regulated expression levels at PND 14 (p<0.05*) in 
cortex (G). Interestingly, FMR1 mRNA expression of MECP2 mRNA expression reversed at 
PND 14 when comparing Pb
2+
 rats to controls (A). Pb
2+
 exposure down regulated FMR1 and 





 Figure 14.showed that in cortex  FMR1 and MECP2 mRNA expression levels were 
disrupted resulting in an Age effect (DF=3, MS=1.21, F=50.98, p<0.001***), a Treatment effect 
(DF=1, MS=0.15, F=6.49, p<0.02*), a Gene effect (DF=1, MS=0.63, F=26.61, p<0.02*), an Age 
X Treatment interaction (DF=3, MS=0.093, F=3.95, F=0.02*) and an Age X Gene interaction 
(DF=1, MS=0.08, F=3.19, p<0.04*) (A). 
 Figure 14. showed that in hippocampus FMR1 and MECP2 mRNA expression levels 
were disrupted resulting in an Age effect (DF=3, MS=2.48, F=32.73, p<0.001***), a Treatment 
effect (DF=1, MS=0.47, F=6.2, p<0.02*), a Gene effect (DF=1, MS=0.63, F=8.36, p<0.01**) 




 We examined Pb
2+
 effects on gene expression during early development in cortex and 
hippocampus.  The qRT-PCR data revealed that Pb
2+
 decreases VSCC- β 3 mRNA expression at 
PND 7, 14, and 22 in cortex and PND 7 and 22 in hippocampus when compared to control rats 
(Figure 11-A & B.). Pb
2+
 effected these genes differentially resulting in the VSCCs mRNA 
down regulation in expression, whereas the GABAAR-β3 mRNA expression was observed to 
increase in cortex at PND 2, 7, and 14 then decreased at PND 22 from control rats (Figure 11-
A.). Interestingly, in hippocampus the GABAAR-β3 mRNA expression was decreased at PND 7 
and 22 under Pb
2+
 treatment (Figure 11-B.). These findings suggest that GABAAR-β3 mRNA 
increases expression when VSCC- β 3 mRNA decreases in response to Pb
2+
 insult. 
 With respect to the chloride transport proteins that regulate the GABA-shift, we observed  
increased NKCC1 mRNA expression at PND 2 and 7 in cortex (Figure 12-A.), whereas in 
hippocampus an increase at PND 2 was noted and then a decrease at PND 22 when compared to 
control rats (Figure 12-B.).  The KCC2 mRNA was shown to decrease at PND 2 and increase at 
PND 7 in both cortex (Figure 12-A.) and hippocampus (Figure 12-B.) when compared to 
control rats.  Notably, in cortex at PND 14 KCC2 mRNA expression was decreased (Figure 12-
A.), whereas in hippocampus it was increased under Pb
2+ 
treatment (Figure 12-B.).  These 
findings suggest brain regions specific differences in the proteins required for the onset of the 






 exposure.  However, the ratio of the NKCC1 and KCC2 transport proteins and their 
functional activation through phosphorylation remain to be elucidated under Pb
2+
 exposure. 
 To determine how Pb
2+
 may affect early GABAergic neurons we investigated how early 
GAD 80 and 86, as well as, late GAD 65 and 67 mRNA expression altered during post natal 
development.  We observed that in cortex GAD 80 and 86 mRNA expression increased at PND 2 
and 14 when compared to control rats (Figure 13-A.).  In hippocampus, GAD 80 mRNA 
expression decreased at PND 2, whereas GAD 86 increased at PND 2 in response to Pb
2+
 
treatment (Figure 13-B.). At PND 14 both GAD 80 and 86 increased in hippocampus when 
compared to control rats (Figure 13-B.).  
 With respect to late GAD 65 we observed in cortex that mRNA expression increased 
from PND 2 through 14 and decreased at PND 22 under Pb
2+
 exposure (Figure 13-A.).  In 
hippocampus, GAD 65 showed decreased mRNA expression at PND 2 and 7 in response to Pb
2+ 
(Figure 13-B.). In cortex GAD 67 mRNA expression was observed to increase at PND 7 and 
decrease at PND 22 (Figure 13-A.), whereas in hippocampus a decrease in GAD 67 mRNA 
expression was observed at PND 7 and PND 22 (Figure 13-B.).  These findings suggest that 
Pb
2+
 interferes with early GAD 80 and 86 that prolong early GABAergic excitation during 
development.  Together, these findings show a direct effect of Pb
2+
 insult unto GABAergic 
neurotransmission during critical stages of development with the temporal programming of 
GABAergic networks at the transcriptional level. 
 In order to assess how Pb
2+
 would affect presynaptic neurotransmitter vesicular release 
and post synaptic plasticity we evaluated the changes in mRNA expression for MECP2 and 
FMR1 respectively during development.  In the cortex, Pb
2+
 exposure caused increased MECP2 
mRNA expression at PND 14 when compared to controls (Figure 14-A.).   In hippocampus Pb
2+
 
decreased mRNA expression in PND 7 and 22 (Figure 14-B.).  In cortex FMR1 mRNA 
expression was observed to increase in PND 2 and 7 followed by a decrease at PND 14 (Figure 
14-A.), whereas in hippocampus decreased mRNA expression was shown at PND 7 in response 
to Pb
2+
 (Figure 14-B.).  These findings indicate that in cortex at PND 14 Pb
2+
 perturbs vesicular 
release and post synaptic plasticity.  In hippocampus at PND 22 Pb
2+







4.0- Chronic gestational Pb2+ exposure reduces GABAAR expression developmentally and 






 Experimentally naïve male Long Evans Norwegian Hooded rats (Taconic, N.J.) (Control 
n = 12; Pb
2+
 n = 12; n = 3 for PND 2, 7, 14, and 22). Long Evans male and female rats were 
paired. Rats were fed as described in section 2.1.1. 
 
 4.1.2- Brain slice immunohistochemistry 
 
 At postnatal day (PND) 2, 7, 14, and 22 rats were sacrificed and perfused 15 minutes 
with PBS followed by 10 minutes  4% PFA.  The following 24 hours, brains were transferred 
into 30% sucrose in PBS.  Brains were aligned to cut mid-sagittal sections on a cryostat with 
O.C.T. TissueTek® compound at 
-
26°C. Brain sections were cut in 30µm thick slices and 
transferred to a 12 well plate with cryoprotectant 30% glycerol, 30% ethylene glycol, and 40% 
PBS for floating immunohistochemistry (IHC). Repeated serial sections were collected in each 
well to increase reliability of staining between slices.  Slices were blocked with 2% NFDM-PBS, 
10% NGS, and 0.02% Triton X100, washed for 30 minutes and blocked in same solution without 
Triton X100 with primary antibodies MS x GABAAR beta chain (MAB341 Chemicon 
International), MS x KCC2 (MyNeuroAb) and Rbt x Calcium 3 (AB5230-200Ulb Chemicon 
International) then incubated for 24 hours at
 -
4ºC. The following secondary antibodies were used: 
goat anti-Ms FITC (ab’) 2 (Santa Cruz Biotechnology) and Cy5 goat anti-Rbt (Santa Cruz 
Biotechnology). For confocal data, the FITC fluorophore was excited at 488 nm; the Cy5 at 633 
nm.  Emission for these dyes are in the green and red range, respectively.  Slices were transferred 
onto gelatin-coated slides manually and mounted with Slow Fade Gold anti-fade reagent with 






 4.1.3-Primary neuronal granule cell cultures 
 
 Twelve postnatal day 6 male rats were sacrificed and cerebellums were dissected away 
from the rest of the brain under sterile conditions. Cerebellums were washed 3 xs with calcium-
magnesium free phosphate buffered saline (CMF-PBS). Samples were subjected to trypsinisation 
and placed on a manual rotor for 5 minutes.  Samples were washed again 3x with CFM-PBS then 
treated with DNase and triturated sequentially 10xs with 3 pasture pipettes of decreasing size to 
dissociate cerebellar granule cells. Samples were left to sit on ice and 2 minutes later the 
supernatant was collected and transferred to a new tube. Samples were then centrifuged at 4°C 
for 1,000 RPM for 5 minutes. DNase was then removed from the sample leaving only the pellet, 
which was then resuspended in 1mL of Minimum Essential Medium (MEM) Eagles Serum. 
Samples were triturated again in the same manner as before. A 1:10 dilution of sample into 
MEM was used to count cells using a hemocytometer.  Desired cell suspensions were calculated 
using a dilution factor to yield 1.5x10
6
 cells per poly-D-lysine coated cover slip in a 24 well 
plate.  The next day MEM was replaced with fresh MEM containing N2 supplement and cells 
were treated with dose responses of PbCl
- 
(i.e. 0.05μM, 0.1 μM, 0.5 μM, 1 μM, and 1.5 μM). The 
following day (i.e. 3
rd
 day in vitro) cells were fixed and subjected to IHC same as the procedures 
above.  
 
 4.1.4- Confocal microscopy and Imaris image processing 
 
 Tissue were visualized under a Leica SP2 AOBS confocal microscope with a 40x oil 
objective for brain slices and a 63x oil objective for primary neuronal granule cell cultures. Z-
stacks were taken of the sections and regions of interest.  Images were then quantified using the 
Imaris software (Bitplane, South Windsor CT) digital intensity mean analysis and reconstruction 
of the sections. All settings were equivalent within comparative brain/granule cell culture regions 








Treatment X Protein ANOVA was used to identify factor and interaction effects.  Significant 
differences were determined by either an equal or unequal N Tukey’s HSD post hoc comparisons 




         
Figure 15. Pb
2+
 effects on KCC2 expression (Green) patterns in cortex as a function of age. 
          
Figure 16. Pb
2+






Figures 15-16 showed an Age effect (DF=3, MS=146,787, F=150.895, p<0.001***) and an Age 
X Treatment interaction (DF=3, MS=78,563, F=80.762, p<0.001***). 
 
              
Figure 17. Pb
2+
 effects on KCC2 expression (Green) patterns in dentate gyrus as a function of 
age. 
          
Figure 18. Pb
2+






 Figures 17-18 showed an Age effect (DF=3, MS=175,754, F=167.295, p<0.001***), a 
Treatment effect (DF=1, MS=71,122, F=67.6999, p<0.001***), and an Age X Treatment 
interaction (DF=3, MS=51,263, F=48.796, p<0.001***). 
 
               
Figure 19. Pb
2+
 effects on KCC2 expression (Green) patterns in CA3 as a function of age. 
 
          
Figure 20. Pb
2+
 effects on KCC2 IHC mean intensity expression in CA3 as a function of age. 
 




Treatment effect (DF=1, MS=72,474, F=55,274, p<0.001***), and an Age X Treatment 
interaction (DF=3, MS=37,357, F=28,491, p<0.001***). 
            
Figure 21. PbCl
-
 alters GABAAR expression (Green) in culture and VSCC-β3 nuclear 
translocation (white arrow pointing to Red) in cerebellar granule cell cultured neurons. 
(uppercase letter shows field and lower case letter shows magnified cell). Images were taken 





          
Figure 22. PbCl
-
 induces a curvilinear effect on VSCC-β3 nuclear expression in cerebellar 
granule cell cultured neurons. 
 
 Figure 22. shows a curvilinear relationship between increased dose responses of PbCl
-
 on 
increasing VSCC-β3 nuclear expression at lower and decreased nuclear expression at higher 
doses.  PbCl
-
 has a treatment and Dose effects as independent factors in a one way ANOVA 





       
Figure 23. PbCl
-
 induces a curvilinear effect on GABAAR expression in cerebellar granule cell 
cultured neurons. 
 
 Figure 23. shows a curvilinear relationship between increased dose responses of PbCl
-
 on 
GABAAR expression in cerebellar granule cell cultured neurons. PbCl
-
 has a treatment and Dose 
effects using a one way ANOVA (DF=5, MS=880,243, F=598.4, p<0.001***) with an unequal 





             
Figure 24. PbCl
-
 decreases KCC2 expression (Green) in cerebellar granule cell cultured neurons 
regardless of dose (uppercase letter shows field and lower case letter shows magnified cell). 





           
Figure 25. PbCl
-
 reduces KCC2 expression in cerebellar granule cell cultured neurons regardless 
of dose. 
 
 Figure 25. shows a decreased KCC2 expression in cerebellar granule cell cultured 
neurons in response to PbCl
- 
regardless of dose. PbCl
-
 has a Treatment and Dose effects using a 





 Our data showed that in the gestational rat model Pb
2+
 toxicity prematurely shifted  
KCC2 protein expression for PND 7 to PND 2 in cortex, DG, and CA3 regions of the 
hippocampus evidenced by immunohistochemistry (Figures 15-20.).  In addition, the normal 
trajectory of KCC2 peak expression was observed at PND 14 in cortex, DG, and CA3 in control 
rats (Figures 15-20.).  Interestingly, in the cortex Pb
2+
 exposure reduced KCC2 
immunoreactivity at PND14 and PND 22 when compared to controls (Figures 15-18.). In the 
DG Pb
2+
 decreased KCC2 immunoreactivity at PND 14 and remained elevated in contrast to 
controls at PND 22 (Figures 19-20.).  These findings implicate that gestation Pb
2+




prematurely increase expression of KCC2 resulting in a premature GABA-shift in early 
development resulting in altered excitation-to-inhibition balancing and an inappropriately wired 
brain.  
 In order to assess the exact effects on the VSCC-β3 and GABAAR expression as a 
function of increased Pb
2+
 exposure we examined the dose response effects of PbCl
-
 in primary 
cerebellar granule cell cultured neurons 3 days in vitro (3 DIV). Our results showed that PbCl
-
 at 
low concentrations increases VSCC-β3 and at high concentrations reduced immunoreactivity 
with peak expression at PbCl
- 
0.1µM in contrast to control conditions (Figures 21-23.). These 
findings describe an atypical dose response curve where higher doses of PbCl
-
 may appear to be 
less detrimental, but result in irreparable neurotoxicity.  Essentially, other neurobiological 
factors, such as astroglia cells, may help compensate with mediating high doses of PbCl
-
, 
whereas at low doses such compensation may not be possible. 
 Interestingly, the cerebellar granule cells GABAAR immunoreactivity showed similar 
effects as did the VSCC-β3 (Figures 21-23.); however, peak expression of GABAAR was 
observed at PbCl
- 
0.5µM. These findings showed that VSCC-β3 is more sensitive to PbCl
- 
insult 
and the early GABAergic system is altered suggesting interference with increased VSCC-β3 and 
GABAAR synergistic activity at low and reduced synergistic activity with high doses of PbCl
-
. 
 When we applied the same dose response of PbCl
-
 to the cerebellar granule cells we 
observed a drastic decrease in KCC2 immunoreactivity (i.e. ~40-50%) irrespective of dose; 
indicating that PbCl
-
 produced delays in the GABA shift in isolated cultured neurons when 
compared to control conditions (Figures 24-25.). These findings indicate that Pb
2+
 can interrupt 
early GABAergic development through perturbing the precise interplay between the VSCC-β3 
and GABAAR; thereby secondarily affecting KCC2 expression resulting altered excitation-to-









5.0 - Chronic gestational lead
 
exposure enhances spontaneous and inhibits stimulation-
evoked release of glutamate analog, D-2, 3,-
3
H-aspartic acid from synaptosomes in early 






 Experimentally naïve male Long Evans Hooded rats (Taconic, N.J.) Rattus norvegicus 
(Control n = 96; Pb
2+
 n = 96) were tested in accordance with The College of Staten Island 
(CUNY) IACUC approval procedures.  Long Evans male and female rats were paired. Rats were 
fed as described in section 2.1.1. Age matched controls were used as a reference group. At 
postnatal days (PND) 2, 7, 14 and 22 rats were selected from each treatment condition (i.e. n = 8) 
for frontal cortex and hippocampal synaptosomal preparations to assess neurotransmitter release 
properties and (i.e. n = 4) for both neurotransmitter uptake and binding studies respectively. To 
assess chronic gestation Pb
2+
 effects as a function of brain injury and plasticity during early 
development we selected the following time points to map a developmental trajectory: PND 2 
during astrocyte proliferation, dendritic arborization, and gonadal hormones of immature neurons 
prior to the critical period, PND 7 during the critical period including synapse formation and 
spine growth, PND 14 post critical periods, and PND 22 as mature neurons (See Review Kolb 
and Gibb, 2001).  
 
 5.1.2-Synaptosomal sample preparation 
 
 Long Evans Hooded rats at PND 2, 7, 14, and 22 were anesthetized with Nembutal
®
 (i.p. 
injection 50mg/Kg) and sacrificed in accordance with The College of Staten Island’s (CUNY) 
IACUC policies and procedures.  In two sets of experiments either frontal cortices or hippocampi 
were dissected, extracted, weighed, and homogenized in a 1:10 dilution (w/v) buffer containing 
0.32M sucrose, 1mM MgSO4, 20mM HEPES and pH adjusted to 7.4 with NaOH 
(Sigma/Aldrich, MO).  Samples were pestled in a glass homogenizer with 18 strokes, and 1ml of 




rpm x 10 minutes at 4°C (Beckman TL-100 Ultra Centrifuge, MD).  The supernatant from the 
sucrose gradient was collected and re-centrifugated at 19,000 rpm x 20 minutes at 4°C, while the 
pellet was discarded. The subsequent pellet containing synaptosomes was re-suspended in 800µl 
of oxygenated (O2 95%/CO2 5%) artificial cerebrospinal fluid (aCSF) solution containing 
124mM NaCl, 2mM CaCl2, 4.5mM KCl, 1mM MgCl2, 26mM NaHCO3, 1.2mM NaH2PO4, and 
10mM C6H12O6 with pH 7.4. (Sigma/Aldrich, MO) then centrifugated for 2 minutes at room 
temperature (Beckman # 348750 Microfuge, CA).  This step was repeated twice. The 
synaptosomal pellet was then dissolved by pipette in 1ml oxygenated aCSF solution. Lastly, 
200µl of the synaptosomes were used in the experiments that follow. 
 
 5.1.3-Synaptosomal spontaneous and evoked neurotransmitter release experiments 
 Synaptosomal neurotransmitter release samples (i.e. 200µl) were loaded into an 
electrically inducible chamber (Brandel SF-12 Suprafusion System, MD) along with 3µl of 
1mCi/mL D-2,3,
3
H-aspartic acid (ARC, Inc., MO); a non-metabolized glutamate analogue to 
assess Glutamatergic synaptosomal excitability. Samples were incubated for 1 hour while being 
temperature regulated at 37-39ºC.  Perfusion flow rates were adjusted to 90% pumping rate 
(2.25ml/min). After the incubation period, a 30 minute pre-collection period was done to wash 
out excess background radioactivity that was not accumulated into the synaptosomes. The 
experimental samples were collected every 2 minutes in individual scintillation vials. The first 9 
scintillation vials were averaged and taken as a baseline measure of spontaneous release. Sample 
10 was then electrically stimulated with a 10Hz, 10mA stimulus for 20 seconds (Brandel 12 
channel electric stimulation unit, MD) and another 10 scintillation vials were collected post 
stimulation. These remaining samples were taken as measurements of evoked release. Post 
experiment, 3.4ml of ready safe scintillation cocktail liquid (Beckman Coulter™, CA) were 
added to all collection vials capped and vortexed for 10 seconds.  All scintillation vials were set 
in trays for 24 hours. The following day scintillation counts per minute (CPM) were collected for 
10 minutes per vial (Beckman Coulter™ LS 6500 Multipurpose Scintillation Counter, CA).  
 
 5.1.4-Synaptosomal neurotransmitter uptake experiments 
 Watman circle filter papers 24mm (GF/B Circles: Cat: 1821-024) were soaked for 1 hr in 




synaptosomes used in both uptake and binding experiments. Filters were then left to air dry. 
Once dry the filters were placed on the Hoefer Scientific Model # FH224V/FH225V 10 PLC 
FLTR HLDR w/valves 25mm (San Francisco, CA) followed by installing the valve chambers 
atop the filters. Each chamber was filled with 500µl of aCSF. A radioactive glutamate solution 
was prepared with 2µl of stock D-2, 3,3H-aspartic acid (ARC, Inc., MO) and adjusted to 22ml 
using the same aCSF solution as in the release studies. From this solution 1ml was added to each 
chamber. Synaptosomal samples were prepared identical to the release studies except that the 
synaptosomal pellet was dissolved with a 200µl pipette in 1ml of oxygenated aCSF solution. 
Then 200µl of sample was added to each chamber (i.e. total volume 1.7ml) and left to incubate 
for 2 minutes.  After 2 minutes, each sample was vacuumed out and rinsed with 1mL of aCSF 
then vacuumed 3 times. Samples were then left to air dry for 2 minutes and filter papers were 
collected into scintillation vials and prepared identically for CPM determination as the release 
samples. 
 
 5.1.5-Synaptosomal neurotransmitter binding experiments 
 Whatman circle filters were prepared identically to the uptake studies. Brain 
homogenates from cortex and hippocampus were centrifuged at 3,400g X 20 minutes and 
replaced with fresh binding buffer 4 times to wash out endogenous glutamate (i.e. 1-3μM) to 
create glutamate free synaptosomal samples. Binding buffer comprised of: 30mM Tris-HCl, 
2.5mM CaCl2, and pH 7.3 (Sigma-Aldrich, MO).  From the synaptosomes two equal amounts of 
200μl were placed into separate Eppendorf tubes (i.e. one for hot D-2, 3,3H-aspartic acid (ARC, 
Inc., MO) and the other for cold glutamate) to assess total amount of binding hot glutamate vs. 
hot + cold glutamate binding was determined via a subtraction method divided by the amount of 
protein in the synaptosomal fraction. A 100mM glutamate (Sigma-Aldrich, MO) was made and 
diluted to a 1mM glutamate solution and then a final concentration of 100μM glutamate.  The 
radioactive (i.e. hot) D-2, 3,3H-aspartic acid solution was made by taking 5μl of D-2, 3,3H-
aspartic acid and adding it to 5μl of 1mM cold glutamate.  The cold glutamate sample contained 
200μl of synaptosomes, 200μl of D-2, 3,3H-aspartic acid solution, 300μl of binding buffer and 
80μl of 1mM cold glutamate.  The hot glutamate sample contained 200μl of synaptosomes, 
200μl of D-2, 3,3H-aspartic acid solution, 380μl of binding buffer.  These samples were 




washed 3 times with binding buffer. Samples were then left to air dry for 2 minutes and filter 
papers were collected into scintillation vials and prepared identically for CPM determination as 
the release samples. 
 
 5.1.6-Synaptosomal protein determination procedures 
 The sample tubes from each of the experiments that were prepared for the synaptosomal, 
uptake, and binding experiments were used to quantify the protein concentration (µg/µl) per 1:10 
dilution of sample (mg/ml). Proteins were subjected to a Bradford assay using bovine serum as 
the reference protein with a Bio-Rad DC Protein colorimetric assay kit (BIO-RAD 500-0116, 
CA) according to manufacture guidelines.  Briefly, standards of bovine serum were freshly made 
using the following protein concentrations 0.0, 0.0125, 0.250, 0.5, 0.75, 1.0, 1.25, 1.5, and 
2µg/µl respectively. Standards were run in triplicates simultaneously with unknown proteins 
from the synaptosomal experiments. Using a 96 well plate, 5µl of standards and unknown 
protein samples were added into each well, followed by 25µl of working reagent A+S, and 
finally 200µl of reagent B were added (i.e. total volume 230µl/well).  The plates were gently 
agitated to mix the reagents and were stored in Napco Model 6300 (Surplus Solutions, LLC., 
MA) CO2 incubator for 30 minutes prior to being read at 750nm absorbance spectrum on a 
Spectra Max 340PC microplate reader (Molecular Devices, CA). Protein absorbencies were read 
and data computed using SoftMax Pro® data analysis software.  A standard protein curve was 
calculated using an average of the triplicate samples verses the unknown protein concentrations 
(R
2
 > 0.9) as a function of protein concentration (µg/µl) against optical density absorbed from 
the protein when read at 750nm. 
 
 5.1.7-Normalization of synaptosomal protein against CPM 
 Counts per minute (CPM) of D-2,3,
3
H-aspartic acid were recorded over a 10 minute 
period per sample using a Beckman Coulter LS6500 Multipurpose Scintillation Counter 
(Fullerton, CA). Obtained values for D-2,3,
3
H-aspartic acid CPM data were taken and divided by 
the amount of protein from each respective 1ml sample.  The resultant CPM/mg protein was 
graphed as amount of basal uptake and spontaneous release rates of 3H-D-Aspartate prior to and 
post electrical stimulation. Results from the release studies were normalized against the first 9 






H-aspartic acid release from synaptosomes. In both cases Pb
2+
 exposed 
samples were normalized against controls.    
 In the release studies the CPM/mg protein were collected from the 2 minute incubated 
samples and Pb
2+
 exposed samples were normalized against controls.  For the binding studies the 
CPM/mg protein were collected from both the hot (i.e. D-2,3,
3
H-aspartic acid only) and cold 
glutamate (i.e. D-2,3,
3
H-aspartic acid +100μM glutamate) samples to determine total binding by 
subtracting the difference from a competitive binding from non-competitive binding. 
 
 5.1.8-Statistical analyses 
 All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK).  For the 
spontaneous and evoked release, uptake, binding, and Ca
45
 accumulation studies factorial 
ANOVAs were used to assess Age, Treatment, and Age X Treatment interaction effects. For both 
uptake and binding studies a factorial ANOVA was used to assess Age, Treatment, and Age X 
Treatment interaction effects. Significance levels were set at α= 0.05% with a 95% ± SEM. 
Significant differences were determined by equal and unequal Tukey’s HSD post hoc 




















                   
                    
Figure 26. Effects of chronic gestational Pb
2+
 exposure on spontaneous 3
H
-D-Asparate release in 
cortex (A) and hippocampus (B) as a function of age during early post natal development.  Pb
2+
 






 Figure 26. in the cortex the spontaneous neurotransmitter release studies revealed an Age 
effect (DF=3, F=40.906, p<0.001***), a Treatment effect (DF=1, F=32.74, p<0.001***), and an 
Age X Treatment interaction (DF=3, F=17.36, p<0.001***) (A).  Figure 26. in the hippocampus 
the spontaneous neurotransmitter release studies showed an Age effect (DF=3, F=25.99, 

















             
             
Figure 27. Effects of chronic gestational Pb
2+
 exposure on evoked 3
H
-D-Asparate release in 
cortex (A) and hippocampus (B) as a function of age during early post natal development.  Pb
2+
 
inhibits evoked neurotransmitter release at PND 2 and 7 in cortex (A) and PND 2-22 in 





 Figure 27. in the cortex the evoked release studies showed an Age effect (DF=3, 
MS=11,415, F=6.62, p<0.001***), a Treatment effect (DF=1, MS=10,658, F=6.18, p<0.02**) 
and an Age X Treatment interaction (DF=3, MS=9,239, F=5.36, p<0.001**) (A).  Figure 27. in 
the hippocampus the evoked release studies showed an Age effect (DF=3, MS=4,180, F=6.1, 


















                 
                 




                
                
 




-D-Asparate uptake and binding 
in cortex (A & B) and hippocampus (C& D) as a function of age during early post natal 
development.  Pb
2+
 decreases neurotransmitter uptake at PND2 and increases uptake at PND 7 in 






neurotransmitter binding at PND 2, 14, and 22, but reduces it at PND 7 (C).  In hippocampus 
Pb
2+
 follows the same trajectory, but with a less pronounced effect at PND 7 and with enhanced 
effects at PND 14 and 22 (D). 
 
 Figure 28. in the cortex the uptake studies showed an Age effect (DF=3, MS=1,419.91, 
F=40.58, p<0.001***), a Treatment effect (DF=1, MS=189.69, F=5.42, p<0.05**) and an Age X 
Treatment interactions (DF=3, MS=603.74, F=17.25, p<0.001***) (A).  Figure 28. in the 
hippocampus the uptake studies revealed an Age effect (DF=3, MS=13,319.4, F=21.41, 
p<0.001***), a Treatment effects (DF=1, MS=2,086.28, F=33.85, p<0.001***) and an Age X 
Treatment interaction (DF=3, MS=1,630, F=26.45, p<0.001***) (B).  
   
 Figure 28. in the cortex the binding studies showed an Age Effect (DF=3, MS= 748,317, 
F=29.48, p<0.001***) and an Age X Treatment interaction (DF=3, MS=192,600, F=7.59, 
p<0.001***) (C). Figure 28. in the hippocampus the binding revealed an Age effect (DF=3, 
MS=1,658,008, F=73.66, p<0.001***), a Treatment effect (DF=1, MS=398,405, F=17.72, 
p<0.001***) and an Age X Treatment interaction (DF=3, MS=122,675, F=5.46, p<0.01**) (D).  
5.3-Discussion 
 In the spontaneous vs. evoked 3
H
-D-Asparate experiment, chronic gestational Pb
2+
 
exposure induced early developmental changes in synaptosomal physiology at select age points 
between the cortex and hippocampus (Figure 26-A&B.). In the cortex, Pb
2+
 enhanced 
spontaneous release of 3
H
-D-Asparte at PND 2 and 22 when compared with controls (Figure 26-
A.).  In addition, Pb
2+
 exhibited a significant increase in spontaneous neurotransmitter release at 
PND 2 followed by a delayed and gradual recovery with elevations at PND 22 (Figure 26-A.).  
Peak spontaneous neurotransmitter release in the cortex was observed in PND 14 in controls, 
whereas it was observed at PND 2 in Pb
2+
 treated rats (Figure 26-A.). Interestingly, in the 
hippocampus, Pb
2+
 treatment only exhibited a reduction in spontaneous release at PND 14 
(Figure 26-B.). The peak ages of hippocampal spontaneous release was observed at PND 2 and 
14 in controls, with Pb
2+
 treatment showing a consistent pattern of early elevations in 
spontaneous neurotransmitter release followed by a delayed and gradual recovery by PND 22 
(Figure 26-B.). In contrast to spontaneous neurotransmitter release, in the cortex, Pb
2+
 reduced 
evoked neurotransmitter release at PND 2 and 7 followed by benign effects at PND 14 and 22 
(Figure 27-A.). In hippocampus Pb
2+




PND 7, 14, and 22 as a function of age (Figure 27-B). This indicates that the cortex is most 
vulnerable to Pb
2+
 disruption in neurotransmission at PND 2 and 7, whereas the hippocampus is 
vulnerable at later developmental ages (i.e. PND 7, 14, and 22) (Figure 27-A&B).  
 In the cortex Pb
2+
 reduced uptake at PND 2 and increased uptake at PND 7 when 
compared to controls (Figure 28-A). Peak cortical uptake in controls was observed at PND 7 and 
was significantly greater in Pb
2+
 treated rats at this age. In contrast, in hippocampus Pb
2+
 
treatment resulted in reduced uptake at PND 7 and increased uptake at PND 14 and 22 when 
compared to controls (Figure 28-B). Peak uptake hippocampal uptake in controls was observed 
at PND 14 and was significantly greater at PND 22 in Pb
2+
 treated rats. 
 In cortex peak binding was observed at PND 7 in both treatment groups.  Notably, Pb
2+
 
treatment increased binding at PND 2, 14, and 22, while at PND 7 resulted in a decrease in 
binding (Figure 28-C). Pb
2+
 significantly reduced PND 7 binding and increased PND14 binding 
evidencing a shift in post synaptic communication consistent with developmental delays. The 
same binding effects in response to Pb
2+
 were observed in hippocampi, with the exception that at 
PND 7 no Pb
2+
 effects were noted (Figure 28-D).   
 We evaluated gestational Pb
2+
 effects on cortical and hippocampal synaptosomal 
spontaneous and evoked release, uptake, and binding of glutamate analog, D-2,3,-
3
H-aspartic 
acid which we considered as indicative of changes at Glutamatergic synapses. D-2,3,-
3
H-aspartic 
acid  was selected as a reliable determinant of neurotransmitter properties given that it is not 
metabolized through the glutamate/glutamine/GABA-cycle. In addition, changes observed in 
neurotransmitter properties were due to altered gene and protein expression as a result of chronic 
Pb
2+
 insult, rather than an acute in-vitro test solution application.  Interestingly, these lifelong 
changes in neurotransmitter properties by Pb
2+
 produced results consistent with the biphasic 
properties reported in the literature in-vitro.  
 These experiments evidence the three major aspects of neurotransmission: 1) release, 2) 
uptake, and 3) binding of postsynaptic targets.  Pb
2+
 disrupts the efficiency on synaptosomal 
vesicular accumulation of glutamate resulting in increased extracellular glutamate with the 
potential for excitotoxicity, increased glial cells clearing away excess transmitters from the 
synaptic cleft and increased transporter activity to maintain appropriate signaling. Since Pb
2+
 
causes synaptic vesicles to accumulate less neurotransmitter at PND 2 and more at PND 7 in 






spontaneous release of neurotransmitters suggesting altered non-specific transmitter signals 
producing outcomes consistent with altered synaptogenesis in early development. Pb2+ also 
showed an increase in binding at PND 2, 14, and 22 indicating increased glutamate post synaptic 
receptors and sensitivity to glutamate which may be a compensatory mechanism for a reduced 
number of post synaptic contacts if Pb
2+
 resulted in reduced neuronal survival during 
development.  Increasing glutamate post synaptic receptor expression would increase the 
probability of neuron survival in response to Pb
2+
 insult developmentally.  In addition, between 
PND 7-14 there is much brain plasticity to compensate for injuries and enduring insults prior to 




 enhanced spontaneous release at PND 2 in the cortex, whereas in hippocampus at 
PND 14 release was inhibited. Evoked release was inhibited at PND 2 and 7 in cortex and trends 
of inhibition were evident at PND 7, 14, and 22 in hippocampi. These data show Pb
2+
-induced 
cortical aberrations at PND 7 and at PND 14 in hippocampi.  Pb
2+
 reduced cortical uptake at 
PND 2 and increased at PND 7.  In contrast, uptake was enhanced at PND 22 in hippocampi. At 
PND 7 there was reduced binding in cortex, whereas at PND 14 binding was increased in 
hippocampi. We suggest that gestational Pb
2+
 exposure causes imprecision of cortical and 
hippocampal signal-mediated pruning post natally which may obscure relevant signals while 















6.0-Neurobehavioral effects of chronic gestational Pb
2+
 exposure: Taurine as a 






 Long Evans male and female rats were paired. Rats were fed as described in section 2.1.1 
ad libitium from pairing, throughout gestation, and continued through parturition and weaning. 
At postnatal day (PND) one set of 22 rats were assigned to behavioral assays as follows: Open 
Field (OF), Elevated Plus Maze (EPM), Light/Dark Test (LD). Also, independent sets of rats 
were assigned to the Hole Board Test (HB), Context Fear Conditioning Test (CFC) and Auditory 
Cued Fear Conditioning Test (ACFC), and the Acoustic Startle Response (ASR) with pre-pulse 
inhibition (PPI) test to control for carryover effects and to ensure novelty.  Rats were 
administered taurine, a GABAAR agonist, 43mg/Kg i.p. injection 15 minutes prior to behavioral 
testing to assess taurine's influences on GABAergic behavioral regulation in reducing anxiety, 
irritability, stress and increasing inhibitory learning and memory. 
  
 6.1.2-Open field 
 At PND 22 rats were examined during 10 minutes of locomotor exploration in the Open 
Field test (OF) (376mm H x 914mm W x 615mm L) in an illuminated room 300 Lux. This test 
was used to evaluate if there were any locomotor problems and or anxiety issues in the rats 
behaviors. Locomotor variables including time mobile (s) in zone and latency for first exit from 
zone (s) were recorded and post analyzed using the Anymaze® video tracking software 
transmitted via a ceiling mounted SONY-Handy Camera ran to a standard HP 1.6GHz computer. 
 
 6.1.3-Elevated plus maze 
 
 At PND 23 rats were examined during 10 minutes of anxiety testing in the Elevated Plus 
Maze (EPM) (159mm H x 70mm W x 730mm L) in an illuminated room 300 Lux. This tests 




zone entries, time head dipping over open arm ledge, and number of head dips over open arm 
ledge were recorded and post analyzed using the Anymaze® video tracking software transmitted 
via a ceiling mounted SONY-Handy Camera ran to a standard HP 1.6GHz computer. 
 
 6.1.4-Light/dark test 
 
 At PND 24 rats were examined during 10 minutes of anxiety testing in the Light/Dark 
test (LD) (50mm H x 150mm W x 300mm L) in an illuminated room 300 Lux. This test uses 
intrinsic motivation (dark escape) as an anxiety test. Locomotor variables including time in zone 
and time immobile (s) in zone were recorded and post analyzed using the Anymaze® video 
tracking software transmitted via a ceiling mounted SONY-Handy Camera ran to a standard HP 
1.6GHz computer. 
 
 6.1.5-Hole board test 
 
 At PND 30-40 rats were examined during 10 minutes of anxiety testing in the Hole Board 
test (HB) (610mm H x 610mm W x 610mm L) in an illuminated room 300 Lux on day 1. This 
test is a neurotoxicity test that evaluates fear and cognitive behaviors. On day two rats were 
tested in the same chamber and lighting, but 4 olfactory gradients (i.e. vanilla, orange, lemon, 
and almond) were placed in petri dishes below the four corners of the HB test to promote 
exploratory movement. Locomotor variables including time freezing (s) time exploring (s)in 
zone, number of head pokes, latency to first head poke, and time head poking were recorded and 
post analyzed using the Anymaze® video tracking software transmitted via a ceiling mounted 
SONY-Handy Camera ran to a standard HP 1.6GHz computer. 
 
 6.1.6-Contextual fear conditioning 
 At PND 24-30 behaviorally naive rats were transferred to the testing room and remained 
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red 
ambient light. After the acclimation to the testing room rats were gently picked up and placed 
into the context fear conditioning chamber (Med Associates) (215.9mm H x 260.35mm W x 




follows: (a) Day 1 acquisition phase: 120s acclimation, 10s later sound was emitted for 30s 
duration, after 10s of the sound presented a light was illuminated for 10s and during the last 2s of 
the sound a 0.5mA shock was given for 5s in duration as the conditioned aversive stimulus. 
Following the delivery of the shock the rats latency to break 3 infrared beams were measured 
every 10s for 60s followed by a 70s inter-trial-interval.  Three trials were presented during day 1 
which was considered the learning acquisition phase. (b) Day 2 retention phase: The exact same 
testing procedures were administered as in day 1 except that there was no shock delivered.   
 
 6.1.7-Auditory cued conditioning  
 
 At PND 24-30 behaviorally naive rats were transferred to the testing room and remained 
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red 
ambient light. After the acclimation to the testing room rats were gently picked up and placed 
into the context fear conditioning chamber (Med Associates).  This test used sound stimuli paired 
with environmental context to evaluate learning and memory. The testing paradigm was the same 
as the CFC test except that on Day 3 rats were place in an altered context.  The chamber was the 
same size, but was divided diagonally with a black plexiglass (349.25mm) and the floor coated 
with a black rubber mat. On the opposite of the plexiglass where the rats could not access a Petri 
dish was filled with a vanilla extract to stimulate movement in the altered context chamber. 
Motion was recorded for a single trial with a baseline measure for 180 seconds followed by the 
onset of the same auditory cue used in the CFC training during the prior two days.  However, the 
tone lasted 180 seconds.  
  
 6.1.8-Acoustic startle response habituation 
 
 At PND 30-46 behaviorally naive rats were transferred to the testing room and remained 
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red 
ambient light. After the acclimation to the testing room rats were gently picked up and placed 
into the acoustic startle response chamber MED-ASR-Pro1 (Med Associates Inc., VA) for the 
length of the testing session (i.e. 30 minutes). This test evaluates habituation learning to repeated 
exposer to auditory stimuli. All subjects were administered a one block design consisting of 20 





 6.1.9-Acoustic startle response and pre-pulse inhibition 
 
 At PND 30-46 behaviorally naive rats were transferred to the testing room and remained 
in their home cage for 60 minutes in order to acclimate to the test room in the dark with red 
ambient light. After the acclimation to the testing room rats were gently picked up and placed 
into the acoustic startle response chamber MED-ASR-Pro1 (Med Associates Inc., VA) for the 
length of the testing session (i.e. 30 minutes). This test evaluates the rats ability to reduce a 
startling reflex in response to a lower sound preceding a loud sound. All subjects were 
administered a three block design to assess pre-pulse inhibition learning. Block one consisted of 
4 trials with a startle stimuli of 115 dB. Block two contained a random matrix of 16 trials with 
unpredictable prepulses of 75dB, 85dB, 95dB, and 105dB with an ITI of 15 ms. Block three was 
identical to block one. Data were driven via the motion sensor transducer platform and 
transmitted to a standard desktop computer to analyze the data with the supplied Med Associated 
Software. 
 
 6.1.10-Statistical analyses 
 All data were analyzed in Statistica V. 6.1 (Statsoft, Inc. Tulsa, OK).  Factorial ANOVAs 
were used to assess Age, Treatment, and Age X Treatment interaction effects. Significance levels 
were set at α= 0.05% with a 95% ± SEM. Significant differences were determined by equal and 

















                   




 increased anxiety measures in OF and taurine reduced anxiety through 





 Figure 29. The OF test for center zone exploration latency revealed a Tau Treatment 
effect (DF=1, MS=14,459.5, F=8.97, p<0.004**) (A). Figure 29. In the OF the time mobile 
showed Pb
2+
 effect (DF=1, MS=895.92, F=4.08, p<0.05*) and a Tau Treatment effect (DF=1, 



















                 




 showed no difference on EPM anxiety measures, but taurine decreased anxiety 
in control rats and increased anxiety in Pb
2+





 Figure 30. The EPM test for time mobile in zone showed a Taurine effect (DF=1, MS= 
7,946.6, F=6.32, p<0.01 **), a Zone effect (DF=2, MS=49,216.2, F=39.12, p<0.001***) and a 
Pb
2+
 X Taurine interaction (DF=1, MS=6,158.3, F=4.9, p<0.03*) (A). Figure 30. The EPM test 
for number of zone entries revealed a Pb
2+
 effect (DF=1, MS=642.14, F=6.86, p<0.01**), a 
Taurine effect (DF=1, MS=1,138.62, F=12.16, p<0.001***), a Zone effect (DF=2, 
MS=2,389.47, F=25.51, p<0.001***) and a Pb
2+
 X Taurine interaction (DF=1. MS=571.03, 
















                    
                   
 
Figure 31. Taurine treatment increased anxiety in Pb
2+
 rats evidenced by reduced time head 
dipping over the open arm ledge (A) but showed no difference in total number of head dips in the 
EPM (B). Figure 31. The EPM time head dipping over the open arm ledge showed a Pb
2+
effect 





                 
                
 
Figure 32. Taurine treatment increased anxiety in Pb
2+
 rats evidenced by increased acclimation 
time in light chamber during the first minutes in Pb
2+
 rats and for first 5 minutes in Pb
2+
 & 
Taurine rats in the LD test (A). However, this time spent in the light chamber was time spent 





 Figure 32. The LD test time in light chamber showed a Pb2+ effect (DF=1, 
MS=4,196.16, F=25.80, p<0.001***), a Taurine effect (DF=1, MS=3,538.16, F=21.75, p<0.001) 
and a Pb
2+
 X Taurine interaction (DF=1, MS=3,866.57, F=23.77, p<0.001***) (A). Figure 32. 
The LD test time in light chamber immobile revealed a Pb
2+
 effect (DF=1, MS=2,349.13, 
F=19.73, p<0.001***), a Taurine effect (DF=1, MS=1,812.86, F=15.23, p<0.001***) and a Pb
2+
 
X Taurine interaction (DF=1, MS=2,419.16, F=20.32, p<0.001***) (B). 
 















                 
                
Figure 33. Frequency comparisons between the traditional HB test for anxiety escape behaviors 
(A) vs. a novel exploration test (B). The HB test showed a zone effect in which Pb
2+
 rats had 
reduced head pokes in the center zone, but this trait improved with taurine treatment (A). 
However, the day two’s testing procedures were more sensitive to assess neurotoxic behavioral 
signatures, evidencing reduced number of head pokes in both zones in Pb
2+
 rats and with 





 Figure 33. We used a traditional escape response HB test along with a novel exploration 
HB test to tease apart the anxiety with the cognitive searching responses associated with total 
number of head pokes in this test.  The escape response HB test (A) evidenced a Zone effect 
(DF=1, MS=1,392.56, F=13.1, p<0.001***). In contrast, the novel exploration HB test (B) 
revealed a Zone effect (DF=1, MS=925.25, F=23.22, p<0.001***), a Pb
2+
 effect (DF=1. 
MS=3,346.05, F=83.97, p<0.001***), a Zone X Pb
2+
 interaction (DF=1, MS=206.17, F=5.17, 
p<0.03*) and a Pb
2+















                  
                 
Figure 34. Latency to first head poke comparisons between the traditional HB test for anxiety 
escape behaviors (A) vs. a novel exploration test (B). The HB test showed a zone and Pb
2+
 effect 
in the escape condition, with no taurine differences noted (A). However, the day two’s testing 
procedures were again more sensitive to assess neurotoxic behavioral signatures, evidencing 
increased latency to first head poke by Pb
2+
 rats in the center zone and with recovery under 





 Figure 34. We assessed the differences in latency for first head poke between these two 
test conditions.  The escape HB test (A) showed a Zone effect (DF=1, MS=10,976.8, F=11.53, 
p<0.001***) and a Pb
2+
 effect (DF=1, MS=6,935.9, F=7.2873, p<0.009084**).  The exploration 
HB test (B) revealed a Zone effect (DF=1, MS=135,108.2, F=32.02, p<0.001***), a Pb
2+
 effect 
(DF=1, MS=41,485.2, F=9.83, p<0.003**), a Zone X Taurine interaction (DF=1, MS=22,882.2, 
F=5.42, p<0.02*) and a Zone X Pb
2+
















                
               
Figure 35. Time comparisons between freezing and exploring behaviors (A) and total time 
engaged in hole poking behaviors during these test conditions (B). The HB test showed a Pb
2+
 
and a taurine effect in which Pb
2+
 rats had increased time freezing in the escape condition and 
decreased time freezing in the exploration condition (A); notably, taurine recovered the behavior 
in the exploration condition (A). Interestingly, when comparing the time spent hole poking no 
Pb
2+






showed a significant reduction in the exploration condition and taurine improved these behaviors 
treatment (B).  
 
 Figure 35. We evaluated the differences in time freezing vs. exploring and total time 
spent hold poking in each HB test condition. The behavioral engagement time comparisons 
between tests (A) showed a  Condition effect (DF=1, MS=1,061,194, F=221.88, p<0.001***), a 
Pb
2+ 
effect (DF=1, MS=29,813, F=6.23, p<0.01**), a Condition X Pb
2+ 
interaction (DF=1, 
MS=213,911, F=44.73, p<0.001***), a Condition X Taurine interaction (DF=1, MS=51,794, 
F=10.83, p<0.001***) and a Condition X Pb
2+ 
X Taurine interaction (DF=1, MS=59,831, 
F=12.51, p<0.001***). The comparisons for time spent head poking between tests (B) revealed a 
Condition effect (DF=1, MS=11,918.4, F=26.78, p<0.001***), a Pb
2+ 
effect (DF=1, MS=14, 
878.9, F=33.44, p<0.001***) and a Condition X Pb
2+ 











                
                 
Figure 36. Differences in Context Fear acquisition and extinction learning with respect to 
context (A) and aversive stimuli (B). Pb
2+
 treated rats show no differences in fear learning, but 
have reduced memory consolidation of the prior days learning as evidenced by extinction trials 
in both context (A) and aversive (B) conditions. In addition, Pb
2+
 treated rats were more sensitive 
to aversive conditioning than controls, which may have attributed to poor working memory 





 Figure 36. In the CFC context learning revealed in the extinction condition a Pb
2+
 effect 
(DF=1, F=21.74, p<0.001***) (A). Figure 34. In the CFC aversive learning showed in the 
acquisition trials a Trial X Pb
2+
 interaction (DF=3, F=5.14, p <0.001**), and in the extinction 
trials a Pb
2+


















               
              
Figure 37. Differences in ACFC acquisition and retention learning with respect to context (A) 
and aversive stimuli (B). Pb
2+
 treated rats showed reduced context learning (A), and initial 
sensitization to aversive fear learning indicating stressful conditions that may impeded memory 
consolidation of the prior days learning as evidenced by retention and altered context trials in 





 Figure 37. In the ACFC test during the context condition showed a Pb
2+
 effect (DF=1, 
F=29.03, p<0.001***), a Trial effect (DF=3, F=173.794, p<0.001***) and a Pb
2+
 X Trial 
interaction (DF=3, F=10.09, p<0.001***) (A). In the AFCF aversive stimulus condition revealed 
a Pb
2+
 X Trial interaction (DF=5, F=2.73, p<0.05*) and a Trial effect (DF=5, F=75.718, 
p<0.001***) (B). 
 
                  
Figure 38. Differences in Auditory Cued Context Conditioning and generalization into alternate 
contexts. Pb
2+
 treated rats showed reduced freezing in an altered context when compared to 
controls.  However, once the tone previously paired with aversive foot shock was presented both 
control and Pb
2+
 rats froze equivocally.  This suggests that Pb
2+
 rats may be hyper excitable and 
respond to new environments with increased stress. 
 
 Figure 38.  In the ACFC test revealed a Condition effect (DF=1, MS=18,644,039, 
F=335.41, p<0.001***) and a Pb
2






             
              
Figure 39. Effects of Pb
2+
 on non-associative startle habituation (A) and the effects of Pb
2+
 
treated rats PPI learning through a pre-post startle 115dB intervention and the use of taurine (B). 
The graph illustrates that Pb
2+
 rats are hypersensitive to auditory stimuli and they have delays in 
habituation to non-associative stimuli (A). In addition, Pb
2+
 rats have disruptions in PPI learning 
ability, but recover with taurine treatment. This suggests that taurine may recover GABAergic 
learning and memory impairments induced by Pb
2+





 Figure 39. The startle non-associative habituation test showed a Trial effects (DF=19, 
MS=424,655, F=2.47, p<0.001***) and a Pb
2+
 effect (DF=1, MS=11,108,541, F=64.52, 
p<0.001***) (A). Figure 39. The startle PPI pre and post test comparisons revealed a Condition 
effect (DF=1, MS=125,668, F=130.39, p<0.001***), a Taurine effect (DF=1, MS=22,432, 
F=23.28, p<0.001***), a Condition X Taurine interaction (DF=1, MS=5,777, F=6.0, p<0.01**), 
a Pb
2+
 X Taurine interaction (DF=1, MS=8,193, F=8,50, p<0.01**) and a Condition X Pb
2+
 X 
Taurine interaction (DF=1, MS=10,982, F=11.4, p<0.001***) (B). 
                  
                    
Figure 40. Effects of Pb
2+
 treated rats PPI learning through a pre-post startle 115dB intervention 
and the use of Baclofen. 
 
Figure 40.   There was no Pb
2+
 or Baclofen treatment differences observed. However, there was 











The toxic effects of Pb
2+
 on the developing rat nervous system has been investigated to  
assess early developmental GABAergic disruption and its implications with altering inhibitory 
learning and memory. This goal was achieved using a multi-systems approach: blood lead levels 
(clinical physiology), qRT-PCR (molecular genetics), brain and primary neuronal culture 
immunology (immunohistochemical and cellular approaches), physiological cellular components 
(synaptosomes and protein expression) and finally through learning and memory assessment 
with GABA mimetic drug manipulations in the intact animal (behavioral pharmacology).  
The influence of a 956ppm Pb
2+
 gestational diet (i.e. from birth to sacrifice) resulted in 
pup mean blood lead levels (BLLs measured in μg/dL) at PND 2= 41.83 SEM± 14.17, PND 7= 
34 SEM± 10.4, PND 14= 30.17 SEM± 7.77 and PND 22= 38.67 SEM±10.67. The dams at 
corresponding Pb
2+
 exposure times evinced mean BLLs at PND 2= 37 SEM± 9, PND 7= 41.33 
SEM± 21.33, PND 14= 39.33 SEM± 60.33 and PND 22= 43.6 SEM± 22.3 respectively. In 
contrast, control pups and dams were Pb
2+
 negative. These ages were selected to determine 
neurodevelopmental trajectories of the GABA-shift from excitation-to-inhibition postnatally in 
our model.   
We assessed the changes in GABAergic developmental regulatory mRNA gene 




cortex and hippocampus at the aforementioned ages. Our results indicate a Pb
2+
 induced up 
regulation of Caβ3 mRNA at PND 7 followed by a steady down regulation at PND 14 and 22. In 
hippocampus, Caβ3 mRNA was down regulated at PND 7 and 22. This suggests Pb
2+
 inhibits 




Notably, the GABAAR-β3mRNA expression was slightly down regulated in cortex at 
PND 22, but was significantly down regulated in hippocampus at PND 7 and 22. This implicates 
that the hippocampus is more vulnerable to Pb
2+
 alterations in GABAergic gene expression 
suggesting interruption of inhibitory regulated learning and memory. 
In cortex, NKCC1 mRNA was slightly up regulated at PND 2 and 7 in cortex, whereas in 
hippocampus it was up regulated at PND 2 and down regulated at PND 7 as a consequence of 
Pb
2+
. This suggests a Pb
2+
 specific divergent effect in cortex and hippocampus at PND 7 with 
early Cl
- 
importers increasing hyper polarization in both cortex and hippocampus at PND 2. 
Notably, at PND 7 Pb
2+
 increased hyper polarization would occur due to increased NKCC1 
expression whereas, in hippocampus decreased NKCC1 mRNA expression would result in 
increased depolarization producing premature early brain excitability.   
 In contrast, KCC2 mRNA was up regulated at PND 2 and down regulated at PND 7 and 
14 in cortex; whereas in hippocampus it was only down regulated at PND 2 and 7 then up 
regulated at PND 14  in response to Pb
2+
. This suggests that in cortex Pb
2+
 prematurely switches 
earlier than expected at PND 2 and is delayed until PND 22. In hippocampus KCC2 mRNA is 
reduced at PND 2-7 and over expression is observed as a compensatory consequence for early 
delay in this key GABAergic regulatory protein; resulting in increased Cl
-
 extrusion from the 
transporters and subsequently increasing depolarization. These premature delays and abnormal 
early expression of cotransporters indicate a disruption in the expression of the GABAergic 
networks in response to gestational Pb
2+
 exposure producing an organism with decreased 
inhibitory regulation and increased susceptibility to brain excitability. 
To determine more closely how and when these GABAergic networks are most 
susceptible to Pb
2+




precursors for synthesizing early excitatory GABA (i.e. GAD 80 and 86) and late inhibitory 
GABA (GAD 65 and 67). In cortex, early excitatory GAD80 and 86 mRNA were both up 
regulated at PND 2 and 14 in response to Pb
2+
 indicating lasting expression of gestational 
profiles that should not be present at the observed levels in postnatal life; thus, indicating an 
altered GABAergic system with persistent excitation. The same observation was noted in 




Moreover, late inhibitory GAD 65 was slightly up regulated in cortex (i.e. increased 
inhibition) and down regulated in hippocampus (i.e. decreased inhibition) at PND 7; whereas 
GAD 67 was significantly down regulated at PND 22 in both cortex and hippocampus (i.e. 
decreased inhibition) suggesting an altered influence in regulating GABA-dependent learning 
and memory and increased susceptibility to brain excitability.  
We also assessed MECP2 and FMR1 mRNA to determine whether or not we could 
indicate select alteration in presynaptic vesicular release and postsynaptic plasticity based on our 
previous findings suggesting altered GABAergic networks. In cortex MECP2 mRNA was up 
regulated at PND 14 (i.e. increasing neurotransmitter release); whereas in hippocampus it was 
down regulated at PND 22 (i.e. decreasing neurotransmitter release) in response to Pb
2+
.  
Interestingly, we observed FRM1 mRNA down regulation (i.e. reduced postsynaptic plasticity) 
at PND 14. Together these results indicate that Pb
2+
 induces brain region specific effects with 
different trajectories and some delays in brain wiring and/or maturation that may require further 
evaluation at a physiological level to elucidate how Pb
2+





Following these qRT-PCR findings we evaluated whether Pb
2+
 delays the spatial-
temporal distribution (i.e. the pattern and age of onset) of developmentally regulated KCC2 
expression in the cortex and hippocampus as a function of age.  We observed that in cortex Pb
2+
 
increases KCC2 expression at PND 2 and decreases its expression at PND 14 and 22.  This 
suggests an early inhibition of GABA in the early postnatal cortex in response to Pb
2+
 and a 
decreased inhibition of GABA in adolescence and adult rat brains; consistent with the late brain 
being susceptible to excitability. 
In hippocampus DG region KCC2 expression was increased at PND 2, 7 and 22; whereas 
it was decreased at PND 14.  Moreover, in hippocampus CA3 region KCC2 expression was 
increased at PND 2, 7 and14 then decreased at PND 22 in response to Pb
2+
. This suggests that 
the DG is more susceptible to brain excitability at PND 14; whereas, the CA3 region is more 
susceptible to brain excitability at PND 22. Thus, further suggesting that Pb
2+
 induces brain 
region specific alterations between cortex and hippocampus and inter region changes within the 
hippocampus in response to Pb
2+
.  
We next evaluated in primary neuronal cerebellar cultures harvested from PND 5-7 rats 
and treated 3 days in-vitro (3-DIV) with dose responses of PbCl
-
, whether or not Pb
2+
 can induce 
VSCC-β3 nuclear translocation consistent with our hypothesis indicating the mechanism by 
which Pb
2+
 would alter GABAergic synergistic signaling via the GABAAR and the VSCCs. 
Results show that cultured neurons treated with PbCl
-
 at 0.05μM, 0.1μM and 0.5μM produced an 
increase in immunodetection of VSCC-β3 nuclear expression; whereas at exposures exceeding 
these levels produced negligible nuclear expression when compared to control conditions. 
Moreover, these data suggest that cultured neurons are more sensitive to low dose Pb
2+
 exposure 




mechanisms involved in clearing/removing Pb
2+
 may have been saturated becoming essentially 
inactivated at higher concentrations of exposure.  This may produce more latent effects that can 
further produce neuronal excitability and surrounding glial cell death if exposures remain chronic 
resulting in irreparable neurotoxicity.  
When cultured neurons were exposed to increasing dose responses of PbCl
-
 GABAAR-β3 
expression was  increased at 0.05μM, 0.1μM, 0.5μM and 1μM; whereas at 1.5μM this expression 
was decreased.  This suggests that Pb
2+
 influences the increased expression of GABAARs to most 
likely compensate for the increased neuron excitability produced by Pb
2+
.  In addition, this 
increased excitability produces synergistic effects with VSCCs having increased sensitivity to 
low doses of Pb
2+
, which may act together as a mechanism perturbing early GABAergic 
networks in the developing brain consistent with our hypothesis. 
We also assessed the effects of PbCl
-
 on KCC2 expression in cultured neurons.  Results 
show that KCC2 expression in cultured neurons are inhibited nearly 50% from control conditions 
irrespective of PbCl
-
 dose.  Interestingly, this data is in opposition to what we have shown from 
brain slice immunohistochemistry indicating that there may be some undetermined compensatory 
mechanism preventing the intact brain from exhibiting conditions shown in culture due to 
isolated in-vitro conditions.  
We return our discussion to whether Pb
2+
 interferes with physiological functions at these 
respective ages. To address this question we evaluated the spontaneous and evoked release of 
glutamate analog, 3
H
-D-Asparate, its binding and uptake in synaptosomal tissue fractions from 
cortex and hippocampus to assess neuronal communication in response to Pb
2+
.  Results showed 




-D-Asparate spontaneous release at PND 2, 7 and 22 and was 
reduced at PND 14.  In contrast, in hippocampus 3
H




increased at PND 7 and decreased at PND 14. Comparatively, 3
H
-D-Asparate evoked release in 
the cortex diminished at PND 2 and 7; whereas in hippocampus showed a trend of decreased 3
H
-
D-Asparate evoked release from PND 7, 14 and 22.  
In addition, in cortex uptake was reduced at PND 2 and increased at PND 7; whereas in 
hippocampus 3
H
-D-Asparate uptake was reduced at PND 7 and increased at PND 14 and 22.  
Lastly, in both cortex and hippocampus 3
H
-D-Asparate binding was increased at PND 2, 14 and 
22, but decreased at PND 7. Taken together these data suggest that the synaptic turnover of 
glutamate investigated on the synaptosomal fraction has been significantly modulated by Pb
2+
 
exposure.   
The spontaneous release was increased at early time points with brain region selective 
differences and evoked release was in opposite directions of these findings; evidencing a 
biphasic response of Pb
2+
 having altered the synaptic proteins involved in neurotransmission 
from development rather than being added in-vitro to the synaptosomal fraction preparations. 
Additionally, in agreement with the previous observations of brain excitability the intensity of 
glutamate uptake was observed to change in the following way: 1) due to increased spontaneous 
release by Pb
2+
, synaptosomal fractions had difficulty accumulating Pb
2+
, 2) this diminished 
accumulation resulted in decreased evoked release, 3) there was a significant selectively decrease 
in uptake at PND 2 and increased uptake at PND 7 in cortex; whereas  at PND 14 and 22 
increased uptake was observed in hippocampus. 4) there was increased postsynaptic glutamate 
binding at PND 2, 14 and 22 in cortex. Moreover, there was reduced binding at PND7 in cortex. 
These findings suggest that the cortex and hippocampus are negatively affected by Pb
2+
 
producing increased brain excitability with the cortex alterations proceeding those of the 




These changes show an increase in spontaneous release of glutamate (i.e. non-specific 
signals); which we presume would be the same for any other neurotransmitter; specifically 
GABA. These non-specific signals may inappropriately communicate with incorrect targets or 
over stimulate to correct targets, thereby altering brain excitability during development in 
response to Pb
2+
. In addition, these Pb
2+
 induced effects may cause developmental delays 
brought forth by imprecise neuronal communication efficiency. The impact of such a 
perturbation in early development may manifest in behaviors associated with GABAergic 
regulation, impulsivity control, anxiety, habituation, attentional mechanisms and learning and 
memory processes. 
In order to determine whether or not Pb
2+
 gestational exposure had caused alterations in 
GABAergic mediated behaviors, we subjected animals to a battery of tests for anxiety (i.e. open 
field, elevated plus maze, light: dark and hole board), Pavlovian fear learning extinction and 
altered context and cued conditioning, and acoustic startle non-associative learning and with pre-
pulse conditioning. The responsivity of the rats were then further evaluated through the 
controlled effects of taurine, a GABAergic agonist, given as an i.p. injections of 43mg/Kg 15 
minutes before each test with the exception of the context fear (i.e. as taurine has been reported 
to reduce nociception in the anterolateral pathway and may attenuate pain sensory inputs which 
are used as unconditioned stimuli in classical Pavlovian conditioning).  
In the open field, Pb
2+
 induced fear as evidenced by rats having shorter latencies to 
remain in the center zone and engaging in thigmotaxis (i.e. staying by the walls and not moving 
into the center area).  Interestingly, taurine had reduced anxiety in both controls and Pb
2+
 rats by 
increasing their latency to move from the wall to remain in the center area longer, while freezing 




In the elevated plus maze, taurine increased locomotor activity in control rats in all zones 
and made them more reactive in the open arm; thus reducing their anxiety in this test.  In 
contrast, Pb
2+
 rats were not affected by taurine, with the exception of head dips.  Taurine reduced 
Pb
2+
 rats time and number of head dips suggesting an anxiogenic, rather than anxiolytic effect.  
In the light: dark test, control and Pb
2+
 rats did not differ from one another in anxiety 
profiles.  In contrast, taurine increased initial time freezing in the light chamber for both controls 
and Pb
2+
 rats.  Notably, the Pb
2+
 treated rats given taurine froze substantially in the light chamber 
for the majority of the test session indicating a anxiogenic effect.  
This first set of rats showed preliminary inferences of taurine effects on anxiety based 
behaviors.  Since the open field showed more positive effects on taurine reducing anxiety, we 
decided to use another set of rats in a hold board test which contained a similar arena, with the 
exception of 16 1" holes in the center, to assess whether or not we could evaluate Pb
2+
 induced 
effects on freezing behavior absent of any painful aversive stimuli and if we could further 
augment the Pb
2+
 rats behavior with contextual cues (i.e. odorants) to motivate them to move and 
explore the test environment. The hole board test showed an ability to assess the effects of zone 
within this test (i.e. center vs. outer) similar to the open field, but with greater sensitivity and 




 rats showed increased freezing and prolonged latency to make first head poke as a 
fear escape response when compared to controls on day 1. Taurine had no effects on escape 
latency to first head poke. Interestingly, taurine recovered Pb
2+
 rats exploration latency on day 2 
when compared to Pb
2+
 rats and were equivocal to controls.  Taurine did not produce an effect on 
control rats. Pb
2+




time exploring on day 2 when compared to Pb
2+
 , control and control and taurine rats. The same 
was observed for time spent hole poking.  There were no taurine effects on control rats. These 
data suggest that Pb
2+
 rats may respond to differently to contextual environmental cues.  The 
state of anxiety or distress that the rat undergoes in novel testing situations may be over active in 
Pb
2+
 rats which is why taurine recovers behaviors in the hold board test.  In contrast, control rats 
experience the same contextual environmental cues, but are unaffected by taurine administration; 
suggesting that the Pb
2+
 rats may have an altered GABAergic system which is more sensitive 
than the control rats. 
In order to further assess whether Pb
2+
 rats respond differently to contextual 
environmental cues we subjected another set of rats to a classical Pavlovian conditioning 
paradigm.  This test revealed that Pb
2+
 rats learning abilities are not different from controls, but 
Pb
2+
 rats are more sensitive to aversive stimuli (i.e. Pb
2+
 makes them more reactive to stressors)  
and they are less inclined to pick up the contextual environmental cues due to this elevate stress 
response. The consequence of these Pb
2+
 induced effects produce diminished memory 
consolidation during testing and poor retention during extinction trials 24 hrs later.  
In order to better understand context learning and its contribution to fear acquisition and 
extinction we tested another set of rats and subjected them to an auditory cued and altered 
context test paradigm.  These Pb
2+
 rats exhibited similar problems to the previous groups where 
reduced contextual learning was observed and poor retention; whereas, Pb
2+
 rats exhibited 
increased sensitivity to aversive conditions, were more reactive and still produced poor retention. 
Notably, Pb
2+
 rats were able to evince memory from the initial training sessions in an altered 
context 48 hrs later when they were presented with the conditioned sound that was paired with 




associative penalty in another context; therefore auditory processing was intact.  However, we 
were not certain as to whether or not these animals were hypersensitive to auditory stimuli as 
high reactives, similar to the aversive foot shock.  This was peculiar since in the initial testing 
contextual environment these rats produced poor retention, but in an altered context they froze 
more due to the increased reactivity to the sound duration rather than to context memory. 
To address this last aspect of auditory sensory contribution/impairment to learning and 
memory we subjected rats to the acoustic startle response with pre-pulse inhibition.  This test 
permits us to evaluate the contribution of the rats auditory sensory pathway and its subsequent 
sensori-motor behavior with taurine to determine whether Pb
2+
 decreased inhibition can be 
recovered pharmacologically as a potential therapy for Pb
2+
 exposure.  
We first exposed naive rats to 20 continuous trials of 115dB with varied ITIs and 
assessed their ability to habituate without any other associated cues (i.e. non-associative 
learning). Results showed that Pb
2+
 rats were more reactive to the sound stimulus and took 
longer to habituate than controls.  This confirmed our observation of Pb
2+
 rats being high 
reactives to stressors and this sensitivity could, by virtue alone, reduce learning based on poor 
attentional, increased impulsivity due to high reactivity, and neuronal processes due to a 
compromised/diminished GABAergic system (i.e. reduced GABAergic inhibition results in 
hypersensitivity and increased brain excitation).  
We then tested another set of naive rats under a startle pre-post test followed by a pre-
pulse paradigm (i.e. 75dB, 85dB, 95dB, and 105dB presented randomly prior to the startle 
115dB) to evaluate inhibitory learning of the startle pulse.  The results showed that Pb
2+
 rats had 




taurine had no effect on control rats, but taurine significantly increased inhibition in Pb
2+
 treated 
rats; even more so than controls.   
Lastly, we wanted to assess whether or not the GABAAR or the GABAβR was the 
contributing target of GABA inhibition or lack thereof in response to Pb
2+ 
treatment. To answer 
this question we ran another group of rats and tested them identically, however they were 
administered either 3mg/Kg, 6mg/Kg, or 10mg/Kg of Baclofen, a GABAβR agonist, i.p. 15 
minutes before testing.  The GABAβR showed no differences as an effect of dose in both controls 
or Pb
2+
 treated rats.  Moreover, there were no control (+) Baclofen effects when compared to 
Pb
2+ 
(+) Baclofen indicating that either the GABAβR system was not involved in regulating pre-
pulse inhibition mediated by this behavioral assay and/or the GABAAR plays more of a critical 
role in pre-pulse inhibition then its possible ratio of GABAβRs. In addition, GABABRs can also 
activate glycine receptors on the spinal cord and essentially equally reduce all motor activity in 
this test thereby making it indiscernible to parse between GABABRs influence in a sensori-motor 
task. The selective effects of taurine on recovering the inhibitory learning through the pre-pulse 
test is quite convincing that Pb
2+
 induces stress and hyperactivity due to a reduced GABAergic 
system, which can be ameliorated by taurine.   
This suggests that taken together taurine, or another GABAAR agonist, may be a potential 
exogenous pharmacotherapeutic agent for compensating for Pb
2+
 induced neurodevelopmental 
perturbations and subsequent lifelong effects regarding the following:  1) reduced efficiency of 
the GABAergic system, 2) increased reactivity and hypersensitivity to sensory and aversive 
stimuli, 3) reduced attentional based mechanisms due to elevated stress responding, 4) difficulty 
in habituating to novel environments, 5) and  impaired cognition and memory retention 




In conclusions this body of work has identified the following: 
 
 Gestational Pb2+ interferes with immature neuronal VSCCs and GABAAR mediated gene 
regulation in early development which has never been reported in this framework we 
present here. 
 Specifically, gestational Pb2+ alters the expression pattern of the genes regulating the 
GABA-shift in cortex and hippocampus. Brain regions are differentially affected. 
 Gestational Pb2+ induces developmental delays through altered expression of KCC2 
differentially affecting cortex and hippocampus excitation-to-inhibition signaling. 
 Gestation Pb2+ induces altered neurotransmitter signaling resulting in increased brain 
excitability post synaptically. 
 Gestational Pb2+ disrupts GABAergic regulation of emotional and cognitive behaviors 













Future studies based on what we report here can be designed in the following ways to 
further this body of work: 
 
 Investigate the effects of gestational taurine and Pb2+ exposure in potentially ameliorating 
Pb
2+
 induced gene dysfunction in early development. 
 Assess in primary neuronal cultures taurine and Pb2+ dose responses and their effects on 
VSCC-β3, GABAAR-β3, and KCC2 expression. 
 Characterize the GDP profiles in hippocampus at PND 2, 7, 14, and 22. Then assess dose 





 altered gene expression. 
 Assess seizure susceptibility as a result of increased brain excitability induced by Pb2+ 
under GABAergic and Glutamatergic pharmacology. 
 Assess more advanced cognitive behavioral tests to understand Pb2+ induced impulsivity 
























 Here we evaluated through qRT-PCR, immunohistochemistry of brain slices and primary 
cerebellar granule cell neuronal cultures, synaptosomal physiology, and behavioral 
pharmacological assays the effects of Pb
2+ 
on GABAergic neural development in the rat model.  
Our data suggest that Pb
2+
 causes disruption of the GABA shift prior to glutamatergic activation.  
These disruptions in early brain wiring result in altered brain connections, disrupted 
synaptogenesis, and diminished GABAergic inhibition-to-excitation balancing resulting in hyper 
excitable, stress sensitive and learning compromised rats.  In addition, GABAAR drugs may be of 
benefit to investigate as potential neuroprotective target therapies in this experimental model of 
Pb
2+
 toxicity.  Notably, other rodent strains and gender differences may not share the same 
outcomes identified in our studies. In addition, the timing at which and exposure of Pb
2+
 may 
produce varied effects; however our model was restricted to a 956ppm Pb
2+
 exposure level that 
began gestationally and proceeded throughout life. When such a pharmacotherapeutic 
intervention of GABAAR drugs should begin is unclear at this time, but evidence from this body 
of work suggest it may be of value.  Early intervention would appear best. However, too much 
GABAergic activation may present with the same resultant issues identified here as increased 
brain excitability throughout life.  We would suggest that the best time to intervene may be best 
suited during the postnatal day 7-14 plastic 'critical period' (i.e. defined as the period when 
astrocyte proliferation, dendrite growth, synapse formation, and spine growth are maximal).  
This ‘window’ would permit therapeutic action and possible increase the survival of many 
necessary neurons during synaptogenesis increasing the ratio between plasticity-to-pruning. We 
suggest that gestational Pb
2+
 exposure causes a reduced accuracy in the precision of cortical and 




while increasing non-specific background activity resulting in inappropriate or improper network 
connections that persist throughout the lifespan consistent with cognitive impairments purported 
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